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Abstract
A vast number of microbes co-inhabit the human body at a wide range of
anatomical sites where they engage in a multitude of tasks critical to human
health. Among other roles, they provide resistance against invasive microbes,
aid in digestion of nutrients and modulate behavior via the production of sig-
naling molecules. Despite their crucial role in maintaining the normal health,
microbial communities have only been investigated to a limited extent due to
the difficulty of cultivating the majority of microbes outside of their natural envi-
ronments. However the advent of next generation sequencing, increased com-
puting power and vast storage systems over the past decade have provided
the opportunity to study the human microbiome with unprecedented resolution,
leading to a steep increase in the number of metagenomic studies centered
around healthy and diseased human microbiome. As a result we now know
that many complex infectious diseases arise due to compositional shifts in the
endogenous microbial community rather than as a result of colonization by a
single pathogen. Thus it is necessary to derive a detailed characterization of
the complete microbial community rather than single pathogens in order to de-
sign effective management and treatment strategies.
In this work, we use high throughput sequencing to draw detailed taxonomic
and functional characterizations of microbial communities present in diseased
and healthy individuals. To gain this insight, we examine the microbial commu-
nities of two distinct anatomical sites. In the first study, we investigate the lung
microbial community of cystic fibrosis (CF) patients with chronic respiratory in-
fections, to determine the community composition and identify specific genomic
adaptations that microbes undergo during the course of an infection. Crucially,
we use total DNA from expectorated sputum without prior depletion of human
DNA to provide a comprehensive view of the airway flora. We perform strain typ-
ing of abundant lung colonizers to provide a high resolution taxonomic charac-
terization, using well populated multi locus sequence typing (MLST) databases.
This method provides a less cumbersome alternative to classical MLST for
strain identification and tracking pathogen evolution during disease progression.
We show that genomic analysis in conjugation with routine clinical diagnostics
can help identify emerging, previously unidentified pathogens and distinguish
them from other closely related species. Interestingly, we identify a likely new
Achromobacter species in a CF lung which can be easily mistaken for its close
relative A. xylosoxidans, an opportunistic CF pathogen, in the absence of such
genomic analysis. We further study strain specific adaptations present in a mul-
tidrug resistant (MDR) opportunistic pathogen, S. maltophilia, by reconstructing
1
its near complete genome. Identification of new adaptations not only allows
tracking pathogen evolution but can also provide a unique opportunity to iden-
tify unique targets for designing anti-virulence drugs for effective management of
otherwise resilient MDR microbes, especially in patients suffering from chronic
infections. In this specific MDR microbe, we identified the presence of a recently
incorporated virulence associated secretion system in its CF-associated strain.
We also observed the presence of antibiotic resistance conferring gene sets
by analyzing the lung metagenome of CF patients and found good agreement
between clinical and genomic predictions. These findings suggest that routine
metagenomic surveys of CF sputum microbiome can provide complementary
information to routine clinical investigations to prepare extremely detailed infec-
tion histories and design more informed and effective treatment strategies.
Outside of infection, microbial communities associated to different body sites
evolve dynamically over extended periods of time. To characterize the evo-
lutionary aspect of microbial communities, we turned to the ancient oral micro-
biome which we studied using high throughput sequencing on two calcified den-
tal plaque samples (known as dental calculus). Interestingly, we were able to
identify several commensals and opportunistic pathogens implicated in causing
cardiovascular, upper respiratory and oral diseases. While most commensals
detected in the ancient plaque are routine members of the contemporary oral
community, the presence of opportunistic pathogens in the former was indica-
tive of poor oral health. The assembled genomes allowed us to investigate an
ancient strain of a major periodontal pathogen called T. forsythia, wherein we
identified genomic changes and found evidence supporting lack of pathogenic-
ity related genomic islands present in the modern reference strain. On further
functional characterization of the ancient oral metagenome, we detected the
presence of several putative antibiotic resistance-conferring gene sets. Surpris-
ingly, this finding indicates that presence of antibiotic resistance mechanisms
in microbes predates the use of antibiotics. Lastly, we also identified a few se-
quences with homology to other eukaryotic genomes of most likely dietary ori-
gin. Thus it can be safely concluded that a lot can be learned about the ancient
oral health, microbiome and diet by analyzing dental calculus.
These two analyses have highlighted the power applying metagenomic se-
quencing to non-invasive samples such as sputum or dental plaque, and the
wealth of information that can be recovered with relative ease. These meth-
ods and the data they can deliver will be very valuable for the development of
personalized healthcare strategies and improved routine health management
practices for healthy individuals.
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Zusammenfassung
Eine grosse Anzahl an Mikroben bewohnen die verschiedensten
Ko¨rperregionen des Menschen, und tragen mit einer Vielzahl von Funktionen
zur Gesundheit des Menschen bei. Unter anderem bieten sie Widerstand
gegen invasive Mikroben, helfen bei der Verdauung von Na¨hrstoffen und
beeinflussen das Verhalten anderer Mikroben durch die Herstellung von
Signalmoleku¨len. Trotz ihrer entscheidenden Rolle fu¨r die Gesundheit des
Menschen, wurden mikrobielle Gemeinschaften bisher nur in begrenztem
Umfang untersucht, da Kultivierungsmo¨glichkeiten ausserhalb der natu¨rlichen
Habitate fu¨r die meisten Mikroben fehlen. Allerdings haben die Entwicklung
von neuen Sequenzierungsmethoden (NGS), schnelleren Computern und
gro¨sseren Speichersystemen die Untersuchung des menschlichen Mikrobioms
in einer bisher unerreichten Auflo¨sung ermo¨glicht. Diese Entwicklungen
haben zu einem Anstieg von publizierten metagenomischen Studien u¨ber
das Mikrobiom von gesunden und kranken Menschen gefu¨hrt. Einige dieser
Studien konnten zeigen, dass viele komplexe Infektionskrankheiten durch
Vera¨nderungen in der Komposition der endogenen mikrobiellen Gemeinschaft
entstehen und nicht etwa als Folge einer Kolonisation durch einen einzigen
Krankheitserreger. Daher ist es notwendig, eine detaillierte Charakterisierung
der vollsta¨ndigen mikrobiellen Gemeinschaften durchzufu¨hren, um effektive
Behandlungsstrategien zu etablieren, anstatt einzelne Krankheitserreger zu
studieren.
In dieser Arbeit haben wir High-Troughput Sequenzierung verwendet, um
eine detaillierte taxonomische und funktionelle Charakterisierung mikrobieller
Gemeinschaften in kranken und gesunden Menschen zu erreichen. Insbeson-
dere wurden mikrobielle Gemeinschaften in zwei anatomischen Ko¨rperregionen
untersucht. In der ersten Studie inspizierten wir die mikrobielle Gemein-
schaft der Lunge von Mukoviszidose-Patienten (auch zystische Fibrose, ZF
genannt) mit chronischer Infektion der Atemwege. Wir bestimmten die mikro-
bielle Zusammensetzung und identifizierten spezifische genomische Anpassun-
gen der Mikroben im Verlauf einer Mukoviszidose-Infektion. Wir analysierten
die gesamte DNA in abgehustetem Sputum, inklusive menschlicher DNA, und
erhielten eine umfassende und unvoreingenommene Sicht auf die Atemwegs-
flora. Fu¨r eine Stammtypisierung und taxonomische Charakterisierung der
mikrobiellen Kolonien wurden etablierte multi-locus sequence typing (MLST)
Datenbanken verwendet. Diese Datenbanken ermo¨glichen eine weniger
umsta¨ndliche Alternative zur klassischen MLST und erlauben die Stammidenti-
fizierung und Entwicklungsverfolgung von Erregern wa¨hrend einer Erkrankung,
ohne den Einsatz von stammspezifischer Reagenzien. Wir konnten zeigen,
dass genomische Analysen in Verbindung mit klinischen Routinediagnostiken
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unbekannte Erreger identifizieren und von anderen eng verwandten Arten dif-
ferenzieren ko¨nnen. Unsere Studie fu¨hrte zu der Entdeckung einer neuen
Achromobacter Spezies in einem Mukoviszidose-Patienten, welche in Abwe-
senheit von Genomanalysen mit der eng verwandten Spezies Achromobacter
xylosoxidans ha¨tte verwechselt werden ko¨nnen. Des Weiteren untersuchten
wir spezifische Anpassungen im Genom des multiresistenten (MDR), oppor-
tunistischen Erregers Stenotrophomonas maltophilia. Fu¨r diese Arbeit wurde
nahezu das gesamte Genom des Erregers rekonstruiert. Die Identifizierung
neuer Anpassungen ermo¨glichte nicht nur das Verfolgen der Evolution des Er-
regers, sondern bietet auch eine einmalige Gelegenheit spezifische Angriff-
sziele fu¨r antivirulente Medikamente zu bestimmen. Dies ist insbesondere bei
Patienten mit chronischen Infektionen von grosser Bedeutung, die oft an wider-
standsfa¨higen MDR Mikroben erkranken. In diesem Fall konnten wir eine in
ju¨ngster Vergangenheit ins Genom eingebaute Virulenz ermitteln, welche mit
dem Sekretionssystem des nahverwandten ZF-Stammes assoziiert ist. Durch
die Analyse des Lungen-Metagenoms von ZF-Patienten haben wir auch die
Anwesenheit von Antibiotikaresistenz-verleihenden Gen-Sets beobachten und
eine gute U¨bereinstimmung mit klinischen und genomischen Vorhersagen erzie-
len ko¨nnen. Diese Ergebnisse legen nahe, dass regelma¨ssige metagenomis-
che Untersuchungen von Mikrobiomen im ZF-Sputum wichtige und erga¨nzende
Informationen zu den klinischen Routineuntersuchungen bieten ko¨nnen und de-
taillierte Infektionsverla¨ufe bereitstellen, um informative und effektive Behand-
lungsstrategien anzuwenden.
Neben Infektionen entwickeln sich mikrobielle Gemeinschaften in ver-
schiedenen Ko¨rperstellen auch dynamisch u¨ber la¨ngere Zeitra¨ume. Um den
evolutiona¨ren Aspekt der mikrobiellen Lebensgemeinschaften zu charakter-
isieren, haben wir das Mikrobiom der Mundflora von sterblichen U¨berresten
von Menschen aus dem 11. Jahrhundert untersucht. High-Troughput Se-
quenzierung wurde angewandt, um die DNA aus zwei Zahnsteinproben zu
inspizieren. Interessanterweise konnten wir mehrere kommensale und op-
portunistische Pathogene identifizieren, welche dafu¨r bekannt sind, Herz-
Kreislauf- und Atemwegs- und Munderkrankungen zu verursachen. Wa¨hrend
die meisten kommensalen Pathogene u¨bliche Mitglieder der zeitgeno¨ssischen
oralen Gemeinschaft sind, ist die Anwesenheit von opportunistischen Er-
regern ein Zeichen fu¨r schlechte Mundhygenie. Die zusammengesetzten
Genome ermo¨glichten uns, den alten Stamm des parodontalen Erregers Tan-
nerella forsythia zu untersuchen. Wir fanden heraus, dass die fehlende
Pathogenita¨t auf genomische Vera¨nderungen zuru¨ckgefu¨hrt werden kann,
welche mit genomischen Inseln in modernen Referenzsta¨mmen in Verbindung
steht. Bei der weiteren funktionellen Charakterisierung der alten Zahnstein-
proben haben wir das Auftreten von mehreren potentiellen Antibiotikaresistenz-
verleihenden Gen-sets beobachtet. U¨berraschenderweise zeigten diese Ver-
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suche, dass das Auftretten antibiotischer Resistenzmechanismen in Mikroben
a¨lter ist als die medizinische Verwendung von Antibiotika. Zusa¨tzlich kon-
nten wir Genomsequenzen identifizieren, welche eine Homologie zu anderen
eukaryotischen Genomen besassen und auf aufgenommene Nahrungsbe-
standteile zuru¨ckgefu¨hrt werden ko¨nnen. Zusammenfassend ko¨nnen wir fes-
thalten, dass die Mundgesundheit, das Mikrobiom und die Erna¨hrung von Men-
schen aus fru¨heren Zeitepochen mit Hilfe von Zahnstein analysiert werden
ko¨nnen.
Beide Studien unterstreichen die Leistung metagenomischer Sequen-
zierungsmethoden fu¨r die Gewinnung von wertvollen Informationen durch nicht-
invasive Proben wie Sputum oder Zahnbelag, die verha¨ltnisma¨ssig leicht
gewonnen werden ko¨nnen. Methoden und Daten welche diese und a¨hnliche
Studien liefern, sollten in naher Zukunft zur Entwicklung von personalisierten
Gesundheitsstrategien und verbesserten Routinen im Gesundheitsmanage-
ment fu¨hren.
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Chapter 1
Microbiomes
1.1 Microbes
Microbes are present everywhere in nature. They can be found at the bottom
of the oceans [55], in soil [129], hot springs [138], on plants [113] and even
in our intestines [77]. Microbes are the most ancient and primitive form of life
present on Earth. They have adapted to survive in extreme conditions and can
derive nutrition from unlikely sources such as antibiotics [26]. Historically, mi-
crobes have been studied mainly in the context of human health and disease
following the initial discovery by Robert Koch that microorganisms are the un-
derlying cause of several diseases. Over the past centuries, our view on their
role has evolved in tandem with our understanding of their purpose. For ex-
ample, we now know that microbes play an important role in ensuring human
health [6], regulating crucial environmental processes such as biological fixa-
tion of elemental nitrogen and carbon, bioremediation of contaminated sites by
degrading pollutants, transformation of metals [108] and assisting in digestion
and assimilation of nutrients in our gut. Without them, life as we know it can not
exist.
Microbes seldom occur in isolation. Rather, they almost always exist as a
part of a community consisting of diverse members which interact with each
other by secreting signaling molecules [88], exchanging genetic material [80]
(via horizontal gene transfer) or by competing for niche and resources [52].
A microbial community along with its surrounding environment can be rightly
called a dynamic ecosystem in which both the community and its environment
co-regulate each other. For example soil associated microbes play an impor-
tant role in regulating plant biodiversity and vice versa [41]. Studies show that
disturbance in this feedback can often result in the invasion of the environment
by exotic plants or microbial species [133] thereby disrupting the ecosystem.
Many microbial communities are found in close association with animals
[69], plants [113] and humans [132]. The individual community members in-
teract with their host in a variety of ways including mutualistic, commensal or
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pathogenic behavior [22]. The spectrum of interactions exhibited by a microbe
can be attributed to its capacity to rapidly adapt to any changes in its surround-
ings. Under stressful conditions, such as low nutrient availability, competition by
co-colonizing microbes, osmotic shock or inflammatory attack by hosts immune
system, microbes resort to different strategies such as metabolizing alternate
sources of nutrition, secreting toxins, altering membrane permeability or becom-
ing dormant to ensure their survival [24]. Such adaptations modify the nature of
interaction between community members with their host. For instance, certain
fungi such as Candida have been observed to commensally inhabit host mu-
cosal surfaces [2]. When this fungus is exposed to environmental stress such
as low nutrient availability, it expresses a certain class of adhesins and hyphal
associated genes that facilitates its ability to outcompete the co-inhabiting mi-
croflora [2]. During this period, it also causes substantial damage to the host
epithelium and transitions from being a commensal to a pathogen.
To understand the complex relationship between microbes and their hosts,
we need to study them with respect to their communities instead of in isolation.
For example, certain bacteria are only pathogenic in the presence of particular
interacting species [48]. However, characterizing a community is an extremely
challenging task since this includes identifying all the community members, in-
vestigating their biotic and abiotic interaction partners and understanding the
nature of these interactions. Traditional methods for identifying microorganisms
involve isolation of microbes from their natural environments and cultivation un-
der controlled conditions in a laboratory. While this method has been used to
study a wide variety of pathogens, most environmental microbes do not grow in
isolation [62] limiting the applicability of this method in exploring environmental
microbial communities.
Modern techniques for identifying the bacterial fraction of a microbial com-
munity rely on sequencing a relatively conserved gene found across all bacteria
such as the 16S rRNA gene [72]. This allows identifying known bacterial genera
and also annotation of new, previously unobserved ones. This method is widely
used to study the richness and composition of environmental bacterial commu-
nities. While it provides a reasonable estimate of the genus level diversity of
the bacterial population it does not capture the diversity originating from other
members of the community.
Another, relatively recent way of characterizing the composition of a com-
plex sample is by sequencing its entire genomic content [43]. This is known as
Whole Genome Shotgun (WGS) metagenomics and has become feasible with
the advent of high throughput sequencing technologies. WGS metagenomic se-
quencing data provides a holistic view of the microbial community as it accounts
for all the archeal, viral, bacterial and even the eukaryotic community members
and the associated host (if any). Sequencing the entire genomes as opposed
to a single marker gene allows for the identification and annotation of microbial
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community members and associated gene repertoires. By correlating these
genes with their functions, a theoretical metabolic potential of the community
can be estimated.
Such metagenomic studies provide deep insight in the functioning of micro-
bial communities and their role in regulating their environment. However, such
studies also produce copious amounts of data, thus providing a unique set of
challenges. Management of the generated sequence datasets is by no means
a trivial task since it requires efficient algorithms for analysis (often requiring
supercomputers or clusters) and databases with very large storage systems
for storing them. The development of such an infrastructure and software re-
quires dedicated resources with constant maintenance. Additionally, lack of
standardization in experimental and downstream analysis renders cross com-
parison between studies a difficult task. In summary, although WGS metage-
nomics seems a promising technology to study microbial communities, several
challenges need to addressed before it can be routinely applied.
1.2 The human microbiome
Every site of the human body hosts a stunning variety of microbes. These mi-
crobes outnumber body cells by a factor of 10 and together comprise the human
microbiome [53]. The sheer variety and abundance of the resident microbiota
has raised questions about their significance for our existence and has become
a deeply investigated area of research. In 2007, the Human Microbiome Project
(HMP) was established to study the composition of the residing microbial com-
munities in different body sites of healthy individuals by the United States Na-
tional Institute of Health [105]. More recently, other international efforts such
as Meta-HIT have provided comprehensive characterization of the human gut
microbiome in Europeans [42]. These studies have generated large 16S rRNA
and WGS datasets providing a preliminary understanding of the function and
importance of the human microbiome.
The microbiome is first acquired at the time of birth and continues evolving
thereafter [100]. The mode of delivery primarily determines the founding micro-
biota of the neonates [38], whereafter breastfeeding and diet significantly shape
the nascent gut microbiome [45]. As the infants grow older and start interact-
ing with their environment, different body sites acquire characteristic microbial
communities that perform a variety of functions crucial to their wellbeing [22],
such as aiding in digestion and metabolism of nutrients, resisting colonization
by invasive microbes [135] and influencing cognitive behavior [97]. Once fully
established, the human microbiome maintains its composition over time in the
absence of external perturbations. However, with aging it stabilizes to a new
equilibrium. For example, vaginal microbiota have been shown to undergo a
shift with menopause [98] and gut microbiota acquire and drop community mem-
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bers with increasing age [84]. The human microbiome is routinely disturbed
due to daily hygiene practices, change in diet [137] and occasional antibiotic
therapies [142]. Figure 1.1 shows changes in the gut microbiome with age,
diet, antibitioc use and state of health such as obese, malnourished or healthy.
The extent of external perturbations determine the magnitude of change in the
community composition. A healthy microbial community is usually not easily
perturbed and in the event of a stress episode is able to quickly regain its sta-
ble community structure and continue to flourish without any long-lasting effects
[22], [21]. Thus resistance and resilience are generally recognized as two char-
acteristic features of a healthy microbial community [5]. However, the resident
microbial community can undergo long-lasting changes following repeated an-
tibiotic treatments [31]. Such treatments may also exert selective pressure for
resistance phenotypes which have become an increasing cause of concern over
the past few decades [8].
Figure 1.1: Overview of the gut microbiome composition across individuals with
differing age, diet, health and antibiotic usage. Diagramatic representation pre-
pared using 16S rRNA and WGS metagenomic studies. Data included for baby
from [71] and [117], toddler [89] and [71], adult [14], elderly [14] and [148]. Fig-
ure reproduced with permission from [99].
For an external invasive species to colonize a body site, it first needs
to breach the immune system, invade the resident microbial community and
then successfully compete for primary nutrition sources or metabolize alternate
sources [67]. Thus colonization by a pathogen can be viewed as a complex in-
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terplay between the immune system, resident microbiota and external invasive
species as depicted in Figure 1.2. Opportunistic infections are often facilitated
by the frequent use of antibiotics, since they destroy a fraction of the stable
microbial community [16] leaving a partially vacant niche that can be easily in-
vaded. For instance, use of certain antibiotics increase the risk of Clostridium
difficile infections [104]. Alteration in the environment can also result in the es-
tablishment of a new species or expansion of a resident community member.
For example, Immunocompromised patients or individuals with weakened im-
munity under stress occasionally suffer from Candida and Aspergillus infections
[81] in the oral cavity resulting from overgrowth of the residing fungal community.
Figure 1.2: Schematic representation of the complex relationship between hu-
man host, its microbiome and disease causing pathogens. Figure reproduced
with permission from [149]
From an ecological perspective, an infection can be viewed as a state where
the endogenous microbial community undergoes a shift due to overgrowth of an
existing or a foreign microbe. Although in most cases it is difficult to attribute a
causal relationship between changes in the microbial community and a particu-
lar disease, functional profiling can nonetheless aid in understanding community
dynamics and the role of each associated microbial member during the course
of infection. In the following sections the microbiome of three relevant body sites
are discussed.
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1.2.1 Oral microbiome
The oral microbiome is a rich, spatially heterogeneous microbial community with
diversity only second to that of the gut microbiome [21]. It comprises of microbes
that inhabit the different surfaces of the oral cavity, namely mucosa, tongue,
palate, gums and teeth. Within this community there is a wide variety of com-
mensal microbes that play an important role in maintaining proper health. These
commensal microbes compete with exogenous microbes for available surfaces
and nutrients thereby providing resistance against infections [63]. However,
under altered environmental conditions these commensal microbes can cause
diseases and turn pathogenic. For instance, a diet rich in fermentable carbohy-
drates along with reduced salivary clearance alters the environment of the oral
cavity to favor the growth of acidogenic and acidouric species [126]. These bac-
teria ferment sugars to produce acidic substrates that facilitate demineralization
of the teeth in turn causing dental caries. Recent studies indicate that peri-
odontitis, a common oral disease manifests as a result of a dysbiotic microbial
community rather than action of a single bacterial species [57].This highlights
the importance of studying microbial communities as a whole rather than in-
dividuals microbes. The knowledge of the underlying changes that occur in a
microbial community during the course of disease initation and progression can
ultimately help in developing better routine practices to manage oral health more
effectively.
Most oral microbes exist as a part of biofilms that adhere to different sites in
the oral cavity [63]. These biofilms are comprised of highly organized collections
of distinct microbial species that are embedded in an extracellular polysaccha-
ride matrix [112]. Their composition and structure is primarily determined by
local heterogeneity of the oral cavity such as difference in salivary clearance,
pH, oxygen content and presence of immunological molecules [3]. Saliva car-
ries nutrients, immunoglobulins and additionally transports bacteria across dif-
ferent oral surfaces, which may lead to the formation of microheterogeneity [3],
[49]. Extrinsic factors such as diet, dental hygiene and smoking are some of
the factors that shape the biofilm structure and composition [49]. High sugar
content food and tobacco smoking have both been shown to alter the compo-
sition of oral biofilms in favor of pathogens [63], [86]. Within biofilms, microbes
engage in a number of synergistic activities such as quorum sensing and cross
feeding [112] which facilitate their growth and survival. Bacteria use quorum
sensing to communicate and coordinate their behaviour and benefit from col-
lective action. Microbes may also engage in quorum sensing to gain compet-
itive advantage over other co-inhabiting species. For instance, the pathogen
responsible for causing dental caries uses quorum sensing to secrete bacteri-
ocins which gives them a competitive edge within their niche [59], [146]. Due
to the close proximity of microbes in a biofilm they frequently engage in the
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exchange of genetic material via horizontal gene transfer [112]. This plays an
important role in the spreading of antibiotic resistance conferring genes within
the oral microbial community. Oral biofilms have been demonstrated to harbor a
wide range of resistance genes even in individuals with no previous exposure to
antibiotics [20]. This could possibly be due to regular exposure to environmental
microbes which results in the introduction of new genes into the microbial com-
munity [103]. These genes are then propagated via horizontal gene transfer.
For instance, metagenomic studies aimed at assessing the spread of antibiotic
resistance genes in the oral microbiome have identified a novel antibiotic resis-
tance mechanism against tetracycline in uncultivable bacteria, indicating a role
of the oral microbiome as a reservoir of resistance genes [34].
Occasionally oral microbes get transmitted to different body sites where they
establish opportunistic infections. For instance, bacterial pneumonia is very of-
ten caused by the aspiration of oral periodontal pathogens into the lower respi-
ratory tract where they establish an infection as a result of reduced mucociliary
clearance as is the case of cystic fibrosis patients [4]. Periodontitis has also
been associated to an increased incidence of atherosclerosis [87] (excessive
thickening of arterial walls). Although the underlying mechanisms for this are
not clearly understood, it’s been observed that individuals with periodontitis are
400 times more likely to suffer a stroke than with individuals with caries or other
oral diseases [56]. In extreme cases, oral microbes have been documented
to enter the bloodstream through mucosal lesions and cause severe infections
at distant organs such as the liver and the brain [25], [116]. Since oral infec-
tions are regularly observed to cause a number of systemic diseases especially
in immunocompromised patients or in patients with preexisting conditions, it is
important to characterize its members and their role in establishing these infec-
tions to develop more informed treatments.
Recent investigations using 16S rRNA studies have shown that there are
approximately 2000 bacterial phylotypes present in the healthy oral cavity [32].
Online databases such as the Human Oral Microbiome Database (HOMD) [32]
aim to provide a taxonomic schema for the unnamed bacterial phylotypes iden-
tified in the oral community. Approximately half of the oral bacterial members
can not be currently cultivated in the laboratory [32]. Thus direct sequencing ap-
proaches can serve as a powerful tool to characterize the uncultivable fraction
of the oral community.
A recent single cell genomics study performed full length genome compari-
son of an uncultivable oral commensal Tanerella BU063 with its closest known
relative Tanerella forsythia, a member of the red complex (group of periodontal
pathogens) [11]. This study detected important differences in metabolic path-
ways, loss in synteny and absence of several virulence associated genes in
BU063 supporting its commensal nature [11]. Such genomic studies provide
deep insights into the evolution of pathogenicity and difference in the nature of
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host microbial interactions among closely related pathogenic and commensal
strains in the oral cavity [11]. Thus direct sequencing approaches can provide
crucial information about oral microbes including the unobserved community
members.
1.2.2 Lung microbiome
Historically, healthy lungs were thought to be sterile [10]. This notion has been
revised in the past decade by several high throughput sequencing studies that
detected the presence of a robust microbial community in the healthy respira-
tory tract [44]. For a long time, recovery of oral bacterial community members
from lung samples was presumed to be contamination during sampling but re-
cent studies have shown that the healthy lungs harbor a microbial community
founded in part by the oral microbiota [19]. While the community composition
has been shown to differ, the strong overlap in the community members is due to
the continuity of the airways. In addition to the oral microbes that are aspirated
into the lungs, the immune system, gut microbiome [96] and the surrounding en-
vironment [136] are some of the other factors that affect the composition of the
lung microbial community. Several studies have tried to account for the effect
of these interaction variables [40] but it has been a challenging task to decipher
their relationships.
Beginning from the nasal passage to the alveoli, the healthy respiratory tract
offers a warm and moist environment for microbes to colonize [35]. However,
he presence of cilia on the respiratory epithelium deters microbes from adher-
ing [15] and the bacteriostatic mucus lining [143] prevents them from growing.
These mechanisms assist in regulating the microbial load in the airways. Lungs
also exhibit substantial spatial heterogeneity in its regional growth conditions
such as temperature, oxygen availability, pH and host epithelial interactions
[139]. This spatial heterogeneity translates only modestly into the formation of
localized communities [35] emphasizing that other factors such as bi-directional
sweeping of the microbes in airway plays a greater role than localized selection
pressures in shaping the community composition [36]. Any disturbance in these
regulatory factors is bound to alter the resident microbial community composi-
tion.
The majority of respiratory diseases have an infectious component, including
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and chronic
bronchitis [12]. These diseases manifest as an interplay between environment,
immune system, genetic predispositions and an imbalance in the residing mi-
crobial community. The lung microbiota of patients suffering from CF or COPD
shows a markedly different composition as compared to healthy individuals. Al-
tered lung environment such as reduced mucociliary clearance in most cases
[37] facilitates the onset of bacterial and fungal infections. Clogging of the
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Figure 1.3: Pictorial representation of the various factors involved in recurring,
chronic lung infections. Figure reproduced with permission from [73]
airways with mucus secretions creates pronounced spatial heterogeneity (hy-
poxic environments) which facilitates localized overgrowth of microbes and also
makes it harder for antibiotics (administered through inhalation) to take effect
[73]. Progressive lung infections have been shown to reduce lung microbial di-
versity over time [150]. This reduction in diversity has also been linked to lung
function decline and poor disease outcome [150]. Figure 1.3 shows that mi-
crobes associated to other body sites such as the oral cavity, skin and gut can
establish polymicrobial respiratory infections within an altered lung environment.
These infections usually trigger an immune response, which besides killing the
microbes also causes inflammation (exacerbations) leading to lung function de-
cline. Additionally, repeated antibiotic treatments to manage the microbial load
results in loss of lung commensal flora and concomittant development of an-
tibiotic resistant microbial communities. The development of such communities
hastens lung function decline and leads to poor disease outcome.
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Microbiome investigations are relatively recent in the context of lungs. A
majority of respiratory microbiome studies have been centered around inves-
tigating diseased states in order to elucidate the role of the lung microbiome
in respiratory infections and recovery. However, there is limited knowledge of
the core microbial community members and their functions in healthy individu-
als. Thus, before any microbiome based treatments for managing respiratory
infections can be designed, large scale population-based studies are required
to characterize the healthy lung microbiome and its dependence on factors such
as age, lifestyle and environment.
1.2.3 Gut microbiome
The gastrointestinal tract, more commonly known as the gut, is home to the
most diverse and complex microbial community within the human body [32].
Studies suggest that the gut microbiome asserts local as well as systemic ef-
fects in maintaining proper health. It does so by playing an important role in the
development of adaptive immunity [60], metabolism of otherwise complex nu-
trient sources [107], biosynthesis of vitamins [74] and neurotransmitters [144],
and providing resistance against colonization by pathogens [135]. The current
estimates suggest that upto 1012 microbial cells colonize per gram of the colon
[140].
The gut microbiome composition is influenced by several intrinsic and extrin-
sic factors including (but not limited to) diet [58], age [134], sex, basal metabolic
rate [39] host genotype and medications [61]. For instance, it has been shown
that a diet with high fat content alters the gut microbial composition both in the
presence and absence of obesity [58]. Besides antibiotics, medication such
as corticosteroids profoundly effect the composition of the gut microbiome [61]
possibly by affecting the immune system. All these factors directly or indirectly
shape the gut microbiome but the extent of their effect has been challenging to
assess. Studies carried out on a geographically limited small sample size have
in the past suffered from the confounding effects of these interaction variables.
However in recent times, studies by the human microbiome project and MetaHit
consortium have tried to account for these factors by collecting population wide
data. The aim of these large scale studies has been to mainly define a core
microbiome associated to the healthy gut (and other body sites), prepare refer-
ence genomes of routinely observed members and delineate their taxonomies
as well as functional characteristics [106] [42]. The objective is to prepare high
quality large datasets and to characterize them for developing a deep under-
standing of the role played by the gut microbiome in maintaing health [106].
The gut harbors a characteristic microbial community that varies greatly in
composition across individuals [132]. These differences have been shown to be
slightly reduced between related individuals but even then a consistent, com-
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mon set of shared bacterial phyla has not be detected [131]. A group of genes
engaged in a core set of metabolic pathways has been observed consistently
in the healthy gut microbiome from different individuals [131]. This indicates
that while the healthy gut demonstrates large variability at the phyla level, it
is functionally conserved at the gene level and engages in similar metabolic
activities. Furthermore, deviations from this core functional profile has been
observed in individuals with unhealthy or diseased conditions. For instance,
obese individuals tend to show decreased microbial diversity and an altered set
of core metabolic pathways as compared to healthy individuals [131]. Patients
with crohns disease and ulcerative colitis exhibit a greater shift in their func-
tional profile as compared to their microbial composition [90]. This indicates
that perhaps a core set of genes and pathways could be a potential alternative
to describing a healthy gut microbiome rather than a shared group of microbial
species.
Colonization Resistance
A healthy gut microbiome in the absence of any external perturbations such as
therapeutics has been shown to inhibit colonization and prevent overgrowth of
several enteropathogens. This characteristic of the gut microbiota is known as
colonization resistance [135] and has been a topic of investigation of many dif-
ferent studies. It has been shown to do so using a variety of mechanisms which
include i. physically colonizing the gut epithelium to reduce anchoring sites for
the invasive species [123], ii. competing for nutrient sources iii. stimulating the
immune system against the invading microbe [118]. The gut microbial com-
position has been shown to effect susceptibility of gut to pathogen invasion, in
particular communities with reduced species richness being more vulnerable to
colonization [122]. While the underlying reasons for this phenotype are not fully
understood, it has been shown that certain members of the healthy human gut
community can actively repress expression of virulence factors by secretion of
metabolites thereby evading infection [29]. Occasionally, despite the resistance
mechanisms employed by the gut community, the enteric pathogens become
successful in establishing an infection. They do so by circumventing the com-
petition for different carbon sources posed by the endogenous community, by
feeding on secondary (i.e. less preferred) carbon sources [65] or showing pref-
erential usage of other nutrient sources as compared to the gut community.
Understanding mechanisms of gut colonization by enteric pathogens and the
role of gut microbiome in controlling nutrient availability provides a window of
opportunity to design methods to manage or even prevent these infections.
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Chapter 2
Classical and modern investigative
methods for studying microbial
communities
Our long standing interest in investigating members of a microbial community
has led to development of new technologies that have facilitated identification
and characterization of microbial communities and their members. In this sec-
tion we will discuss some traditional and recent techniques developed for this
purpose.
2.1 Culture-based techniques
Standard microbial culture requires isolation and growth of a microorganism on
a selective nutrient rich media (most based on an agarose gel), under controlled
clinical conditions to identify and characterize the microbe [70]. To date, this
method has been routinely used as a diagnostic tool in clinical microbiology lab-
oratories to identify pathogens. However, when investigating complex microbial
communities from environmental samples such as soil, a majority of these mi-
crobes can not be cultivated in the laboratory using standard culture techniques
[62]. Thus, over time the traditional cultivation techniques have been revised to
mimic natural environments using a variety of methods. This includes allowing
co-culture of microbes, controlling pH, temperature and oxygen content to imi-
tate their niche variables and finally installing a portion of the actual environment
as a nutrient source to facilitate microbial growth using various micro-cultivation
techniques [124]. With recent advancements in culture techniques, a higher
fraction of environmental microbes can be isolated and grown in the laborato-
ries but even then majority of microbes (around 99%) remain uncultivable [62].
Thus molecular techniques that do not depend on laboratory culture of microbes
are more likely to provide a well rounded view of environmental microbial com-
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munities.
2.2 Culture-independent molecular techniques
Molecular methods that do not rely on isolation and cultivation of microbes for
their identification primarily depend on detecting biomarkers that can be used
as a proxy for the presence of the microbe itself. When phylogenetic marker
genes such as 16S rRNA is used as a biomarker then the bacterial diversity
of the community can be estimated. This is especially useful for assessing
the diversity in samples from which these bacterial members can not be iso-
lated and cultivated in laboratory cultures. Total DNA from such samples is ex-
tracted and then a particular gene of interest such as 16S rRNA gene (i.e. the
biomarker) is then amplified and analyzed using a variety of DNA assays such
as Denaturing- gradient gel electrophoresis [92] (DGGE), Temperature gradi-
ent gel electrophoresis (TGGE), Random amplified polymorphic DNA (RAPD)
[51] and Terminal restriction fragment length polymorphism (T-RFLP) [127] to
extrapolate diversity of the whole community from their readouts. This process
is commonly known as community fingerprinting and is used routinely to track
temporal changes in the bacterial diversity of an environmental site.
An important limitation of all these methods is that they cannot be used to
identify the bacterial members of the microbial community. Moreover, these
assays can be difficult to cross compare when generated from different labo-
ratories and also due to difference in their sensitivity towards lowly abundant
microbes [13]. Since these methods are relatively straightforward and inexpen-
sive they serve as a reasonable option for rapidly assessing the community
diversity before planning elaborate experiments. In recent times, as the DNA
sequencing is getting progressively cheaper, amplicon based sequencing is be-
ing more widely adopted for performing diversity analysis and identifying the
bacterial community members.
2.3 DNA sequencing
Sequencing is a method used to detect the order of nucleotides on a DNA
strand. To perform sequencing, first the DNA needs to be extracted from dif-
ferent samples which can be pure isolates of microbes, environmental sam-
ples such as soil from a farm field, water from the tap, or clinical specimens
as sputum or stool. Once the DNA is extracted, sequencing is performed ei-
ther on the entire DNA content or only on a specific genomic region depend-
ing on the type of research question being addressed. For instance, when the
aim is to investigate the diversity of the bacterial fraction of the microbial com-
munity, delineate their taxonomies or deduce phylogenetic relationships then a
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universally present gene such as the 16S rRNA found in all bacterial genomes
is sequenced [50]. This gene serves as an ideal phylogenetic marker as it is
fairly long (1500 base pair) and contains highly conserved regions that are in-
terspersed by varying stretches of DNA. The conserved regions are ideal for
designing complementary PCR primers to recover amplicons spanning the vari-
able regions. These amplicons can then be sequenced to recover the read-
outs. By converting the differences (mismatches) between the variable regions
of the 16S rRNA gene into a meaningful distance measure, operational taxo-
nomic units (OTUs) can be drawn which are essentially clusters of highly similar
sequences that satisfy a distance cutoff [114]. The number of OTU clusters
found in a microbial community can then be used to measure diversity or esti-
mate the number of bacterial genera present in a sample. Alternatively, when
the functional potential or whole community structure including fungal, viral and
archeal members of the microbial community need to be investigated, the en-
tire genomic content as opposed to a single gene is sequenced. This is known
as whole genome shotgun sequencing (shotgun implies sequencing is done
on fragmented DNA molecules) and has been used to investigate complete
metagenomes to address a wide variety of research questions linked to function
and composition of environment or human associated microbial communites.
2.3.1 Sanger sequencing
Sanger sequencing or also known as chain termination method was first devel-
oped in 1977 [115]. Since then, it has been widely used for sequencing high
quality bacterial and eukaryotic reference genomes. Sanger sequencing was
the primary sequencing technique used for preparing the first draft of the human
genome. Its long read length∼1000 base pairs and low error rate [119] makes it
a gold standard in DNA sequencing technologies. While the accuracy of sanger
sequencing makes it an ideal technique for clinical applications, its prohibitively
high per base cost of ∼ $0.50/base [119] and low throughput makes it less at-
tractive for conducting exploratory analysis on host and environment associated
microbial communities.
In recent times, the original sequencing technique has been sped up by
optimizations such as parallelization using 96 well plates and minimizing manual
intervention. The original technique has been modified to use dyes for detecting
the four di-deoxynucleotides but the sequencing principle is essentially still the
same [125]. Figure 2.1 shows the workflow of the modern capillary based high
throughput sanger sequencer.
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Figure 2.1: Workflow of sequencing technologies. a. Steps involved in capillary
based high throughput sanger sequencing. b. General workflow of cyclic array
next generation DNA sequencing paltforms. Figure reproduced with permission
from [119]
2.3.2 Next generation sequencing
In late 90s, sequencing platforms were designed such that millions of small DNA
sequences could be read in parallel. These massively parallel, high throughput
sequencing technologies are commonly referred to as next generation sequenc-
ing (NGS). One of the first next generation platforms to be commercially was
designed by 454 systems [83]. Since then, many sequencers have been com-
mercially released by companies like Illumina [46],[130], Pacific Biosciences [76]
and SOLiD [120]. The main features of next generation sequencing that sets it
apart from previous methodologies is its low per base sequencing cost and high
throughput [119]. Due to these reasons, it has revolutionized research partic-
ularly in the field of human health and environmental microbial ecology. With
the dramatic reduction in cost, sequencing has become affordable and acces-
sible to a majority of researchers. This has led to a burst in sequencing based
projects. Furthermore, different sequencing techniques (based on detection of
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different fluorochromes, or in change in pH) have opened avenues to address a
broad variety of research questions. Like sanger sequencing, next generation
sequencing is also based on the principle of sequencing by synthesis. While
there are major differences in the specifics of different next generation sequenc-
ing technologies, the basic workflow is largely similar and has been depicted in
Figure 2.1. The library preparation for sequencing begins with fragmenting the
genomic DNA in smaller pieces in the order of 200-600 base pairs. Follow-
ing fragmentation, adapters are ligated to both the ends of all the sequences.
These adapter ligated sequences are spatially fixed or isolated from one an-
other (depending on the sequencer) and are clonally amplified. Thus all the
clones derived from a single DNA sequence are spatially localized on an array.
This array of DNA templates is then flooded with a mixture of appropriate en-
zymes and nucleotides to allow addition of the complementary nucleotide base.
During this process a signature signal of the added nucleotide is released. This
signal is recorded (often by a very sensitive laser) after each flooding step. The
process is repeated to generate readout of desired length. Due to increasing
noise to signal ratio, the base quality decreases over time and this determines
the length of the read outs in different technologies. Specific platform related
details have been summarized in Table 2.1.
Table 2.1: Next generation sequencing technology related specifics. Data
adapted from [119]
While next generation sequencing is a promising technology, it has been un-
able to replace sanger sequencing and establish itself as a reliable technique
to draw clinical inferences. This can be attributed to its relatively higher error
rate in base calling and shorter read length that necessitates elaborate down-
stream data processing. A single Illumina Hiseq4000 flowcell generates up to
1.5 terabyte of sequencing data [75]. Processing such large datasets require
investment in powerful machines and storage systems and need experts for its
analysis. Such elaborate in house setups for data analysis can be prohibitive in
the use of next generation sequencing as a routine clinical tool.
With growing interest in this technology, some of the technical shortcomings
are bound to be addressed with time. As for the downstream analysis, many
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centralized sequencing centers often provide service in data analysis. Though,
in some cases this might not be a feasible option with data privacy concerns.
Irrespective of its current shortcomings, next generation sequencing has in true
sense transformed the study of complex microbial communities since it has en-
abled their investigation in context of their natural habitats. While high through-
put amplicon sequencing studies have shed light on the large bacterial diversity
present everywhere, high throughput whole genome shotgun sequencing has
facilitated their functional characterization thereby aiding in understanding the
role of different community members in the biochemical activities that take place
in an environment.
2.4 Downstream analysis of metagenomic data
As previously discussed, large amounts of data can be produced by indiscrimi-
nately sequencing the total DNA extracted from a complex sample. The study of
this data to gather meaningful information about the residing microbial commu-
nity and its associated host (if any) is known as whole genome metagenomics
[110]. In recent times, there has been a surge in the number of available tools
for the analysis of metagenomic sequence data. However, each tool has its pros
and cons and underlying assumptions that makes it ideal for some datasets and
unsuitable for others. It is therefore important to consider these issues before
embarking on data analysis to save time and money since the cost of re-running
computationally demanding tools can sometimes be higher the sequencing cost
itself [141].
The first step of any biological experiment is sample collection and prepara-
tion which is also a crucial step in metagenomic projects. The choice of sample
determines the quality of data that can be recovered from it and should be such
that it captures the entire community that is to be analyzed. During sample col-
lection, its is highly recommended to record the associated meta information
such as sample source and conditions to facilitate data replication. Guidelines
such as MIMS (Minimum Information about Metagenome Sequence) [145] aid
in comprehensively logging metadata for future reference. Next, depending on
the type and form of the sample such as tissue [102], soil [30], dental plaque
[101] and stool [121] there are tailored protocols available for robust extraction
of DNA. Bead beating has been shown to increase the yield of microbial DNA
since it helps in efficient lysis of microbial cell walls [28]. Often host associ-
ated samples contain a large amount of eukaryotic DNA which can interfere
with the efficient recovery of the microbial DNA. For instance, more than 90% of
the recovered DNA from sputum samples is generally of host origin which can
interfere with the downstream analysis of the associated microbial fraction. In
such cases, DNA depletion protocols that allow removal of host DNA by either
selectively targeting eukaryotic DNA [47] or with physical separation of cells us-
34
ing flow cytometry are generally recommended. If a particular section of the
microbial community is of interest then enrichment methods to capture particu-
lar cell types should be considered[79]. However, protocols aimed at selectively
enriching microbial DNA are also likely to introduce some bias in the data which
trickles through the entire downstream analysis, thus they should be used with
caution.
Figure 2.2: Typical workflow of a metagenomics project
Once the DNA is extracted, the next step is to select an appropriate se-
quencer that returns readouts of appropriate length and acceptable error rate.
Since a majority of metagenomic projects generally use either 454 pyrose-
quencing or Illumina (including projects discussed in this work), these two tech-
nologies will be the focus of the following discussion. The choice of the se-
quencer primarily depends on the research question at hand and this can vary
from analysis of taxonomic diversity using 16S rRNA gene region or any other
single marker gene, recovery of a near complete genome of an uncultivable mi-
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crobial member, identifying polymorphisms in a genomic region, assessing the
gene pool of the entire community. 454 sequencer returns reads of up to 800
base pairs which is often sufficient to capture an entire region of a marker gene
on a single sequence. This makes it ideal for sequencing amplicon libraries.
454 requires relatively little starting material in the order of a few nanograms for
generating single end libraries and has a relatively short run time of a single day
[1]. All these characteristics make it an extremely desirable sequencing technol-
ogy. However, due its base calling method, 454 suffers from an increased error
in the form of indels in homopolymeric regions that can lead to frameshifts in
coding regions. Since these are non-random errors, they are well characterized
and can be identified during data analysis [109]. Additionally, several tools in-
trinsically account for these errors when dealing with 454 generated sequence
data.
Illumina sequencers generate short reads of 150 base pair length with read-
out of upto 300 base pairs in a paired end mode. Unlike 454, it does not suffer
from any systematic errors although the base quality generally drops towards
the rear end of the reads [93]. Thus Illumina generated reads might require
trimming during quality control step. However, it compensates for the short
read length by generating data with high coverage. Illumina sequencers have
a throughtput of around ∼200 million reads per lane, with usually 8 lanes in
a single flowcell. The high coverage also allows multiplexing of samples in a
single lane when shallow depth of sequencing is suffecient, catering to multiple
samples in a cost effective way. It is by far the cheapest in terms of per base
sequencing cost but often requires assembly of short reads into longer contigu-
ous sequences before any reliable conclusions can be drawn from the data.
Like 454, it also requires relatively little starting material for library preparation
but has a much longer run time of around 11 days [128]. The high coverage
sequencing data generated by Illumina sequencers is ideal for calling single nu-
cleotide variations or assessing the entire gene pool of a community. It also
allows distinguishing closely related strain types that are often found in metage-
nomic datasets.
High throughput sequencing data requires assembly i.e. combining over-
lapping reads originating from a single genomic region into longer contiguous
sequences when the aim is to analyze near complete genome of a microbe or
recover sequences spanning entire gene sets. There are essentially two ways
to approach this issue, namely reference-based or de novo assembly [128]. In
reference based assembly, whole genome sequence of a species is used as a
reference to assemble genomes of closely related strains present in a metage-
nomic sample. However, this method is not able to capture synteny (genome
rearrangements) and insertions in the new assembled strain. More commonly,
reads are assembled using de novo assemblers that construct longer contigu-
ous sequences by identifying overlapping regions in reads without the help of a
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reference. These assemblers visualize genomes as directed graphs and con-
struct paths of the graphs by intersecting terminal regions of the reads. Many
genomic de novo assemblers, are based on the underlying assumption that se-
quences belonging to a single genome exhibit uniform coverage and that the
microbial species are mostly clonal rather than a cloud of closely related strains
that exists together. These assumptions are very often violated in metagenomic
datasets and thus many de novo genome assemblers do not perform optimally
on metagenomic datasets. However, these assemblers might perform accept-
ably when there are a few overrepresented, dominating species present in a
sample. Examples of some de novo assemblers are SOAPdenovo2 [82] and
Velvet [147].
Some genomic assemblers have been further extended to address the
above mentioned issues and deal with metagenomic datasets. These include
MetaVelvet [94] and MEGAHIT [78]. Although these assemblers are a consider-
able improvement over the previous generation of de novo assemblers in terms
of performnace on metagenomic datasets, more sophisticated algorithms are
needed that can assemble reads from lowly abundant microbial species. Em-
pirical tests show that assemblers designed for single cell genomic data such
as SPAdes [7] perform well on metagenomic data sets since they perform com-
pound assemblies with varying overlapping lengths (i.e. different k-mer sizes),
to deal with non-uniform read coverage.
Once assembled, contigs can be aligned against reference genomes using
tools like Mauve [111], [27] or Whole genome Vista [17] that are optimized for
whole genome alignments to isolate draft assemblies of closely related strains.
Such assemblies are more likely to capture new insertions and genome rear-
rangements if present in the newly assembled strain. Binning is another ap-
proach that can be used to sort sequences into phylogenetically meaningful
clusters based on an intrinsic sequence quality such as GC content, represent-
ing a taxonomic level such as genus or species. The rationale is that micro-
bial species exhibit a characteristic GC content [91] which is often also rep-
resented in long assembled contigs. This method performs well only for long
sequences since short sequences are not able to accurately capture this infor-
mation. Most binning techniques are unable to distinguish strain level diversity,
clubbing closely related strains into a single bin that represents a heterogeneous
cloud of strains belonging to a species.
After the assembly step, a fraction of the data remains unassembled. Rea-
sons for this might include inadequate sequencing depth or underlying hetero-
geneity. When the data is dominated by short contigs and unassembled reads
then homology based searches are used to divide data into clusters of previ-
ously known species.
To gather information about the different features present in the assembled
contigs and reads, generally homology based search such as BLAST [18] is
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used against a high quality curated dataset. This is often computationally cum-
bersome and time taking for large datasets. Alternatively, feature prediction
tools such as MetaGeneMarK [151] or Metagene [95] can be used to detect
coding regions present in an assembled contig. These tools are essentially
classifiers that have been trained on codon usage information and initiation se-
quences to identify protein coding genes. Once the genes have been identified,
databases such as EggNOG [64], KEGG [68] and PFAM [9] can be used to as-
sign functional annotation to the identified gene sequences. Besides detecting
coding regions, there are several dedicated databases which house high qual-
ity ribosomal RNA sequences such as greengenes and ribosomal database
project which can be used to detect RNA coding genes sequences present in
the dataset.
There have been a number of recent efforts to streamline the process of
metagenomic analysis to allow cross comparison between studies. This has
resulted into the development of several analysis pipelines that essentially in-
tegrate a number of previously discussed tools under a single wrapper. QIIME
[66] and MG-RAST [54] and IMG/M [85] are such analysis pipelines that per-
forms OTU construction and diversity analysis and functional assignment on
unassembled read data. Additionally, some of these tools provide data repos-
itories to store metagenomic datasets which can be publically shared with the
scientific community.
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Chapter 3
About this thesis
3.1 Contributions
In this work, I present detailed characterizations of microbial communities as-
sociated to two body sites. The sites were investigated in separate studies with
the common goal of gaining insight into the taxonomic and functional diversity
of microbial communities using minimally invasive sampling techniques.
In chapter 4, I include the first study wherein I present a comprehensive
analysis of the lung metagenome of healthy individuals, including both smokers
and nonsmokers, and diseased individuals with either cystic fibrosis or chronic
obstructive pulmonary disease. I investigate the lung community composition
for these health categories, detect the presence of antibiotic resistance genes,
identify strain types of abundant community members and reconstruct near
complete genome of a respiratory pathogen. An additional objective of this work
was to assess the capability of sputum samples to provide information pertinent
to the treatment of cystic fibrosis when processed using WGS sequencing. We
summarize that WGS sequencing of CF sputum provides clinically relevant in-
formation in addition to current diagnostic methods and it can be an attractive
alternate to some of the experimental methods which are labor-intensive and
depend on an array of different technologies.
In chapter 5, I present the second study which characterizes the
metagenome of calcified dental plaque in ancient individuals. The objective
of this study was to profile the health and dietary habits of humans living ap-
proximately 1000 years ago. My contributions to this work include detailing
the community composition of the calcified plaques, and providing evidence for
the emergence of antibiotic resistance. I addition to this, I assembled a partial
genome of an ancient strain of Tanerella forsythia which is a contemporary oral
pathogen.
Besides the major contributions described above, I contributed to two other
studies investigating Salmonella typhimurium infection in the mouse gut. The
first study was aimed at understanding the role of microbiota-derived hydro-
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gen during Salmonella infection. Here, I systematically mined the published gut
metagenomes of 6 different species to identify genes encoding for hydrogen
producing and consuming enzymes with the aim of assessing the availability
of hydrogen in different guts. The second project was aimed at characterizing
the dynamics of Salmonella typhimurium infection and the subsequent recov-
ery episode. For this study, I analyzed changes in the expression pattern of a
variety of genes over the course of infection with the objective of investigating
the capacity of inflammatory markers to return to their baseline values following
infection. The results of these two studies are briefly summarized in chapter 6.
3.2 Challenges
The analysis of WGS sequencing data is often complicated by non-conformity
of derived data to the assumptions of standard bioinformatics tools, e.g. if the
sample source is unconventional or a rarity. Such atypical samples are nor-
mally not considered during the design of mainstream analysis tools. This be-
came problematic during the analysis of WGS sequencing data derived from
the metagenome of ancient dental plaque. Due to the extreme age of the sam-
ples (approximately 1000 years), the extracted DNA was extremely fragmented.
This lead to very short sequencing reads of unequal lengths ranging from 20 to
90 base pairs. Since most metagenomic assemblers are not designed to ac-
commodate such samples, a variety of tools were tested and fine-tuned for the
analysis of this unconventional data.
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4.1 Abstract
Background
Cystic fibrosis (CF) is a life-threatening genetic disorder, characterized by
chronic microbial lung infections due to abnormally viscous mucus secre-
tions within airways. The clinical management of CF typically involves regular
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respiratory-tract cultures in order to identify pathogens and to guide treatment.
However, culture-based methods can miss atypical or slow-growing microbes.
Furthermore, the isolated microbes are often not classified at the strain level
due to limited taxonomic resolution.
Results
Here, we show that untargeted metagenomic sequencing of sputum DNA can
provide valuable information beyond the possibilities of culture-based diagno-
sis. We sequenced the sputum of six CF patients and eleven control samples
without prior depletion of human DNA or cell size selection, thus obtaining the
most unbiased and comprehensive characterization of CF respiratory tract mi-
crobes to date. We present detailed descriptions of the CF and healthy lung
microbiome, reconstruct near complete pathogen genomes, and confirm that
CF lungs consistently exhibit reduced microbial diversity. Crucially, the obtained
genomic sequences enabled a detailed identification of exact pathogen strain
types, when analyzed in conjunction with existing multi-locus sequence typing
databases. We also detected putative pathogenicity islands and indicators of
antibiotics resistance, in good agreement with independent clinical tests.
Conclusions
Unbiased sputum metagenomics provides an in-depth profile of the lung
pathogen microbiome, which is complementary to and more detailed than stan-
dard culture-based reporting. Furthermore, functional and taxonomic features
of the dominant pathogens, including antibiotics resistances, can be deduced
supporting accurate and non-invasive clinical diagnosis.
4.2 Background
Cystic fibrosis (CF) is one of the most prevalent genetic disorders in the Cau-
casian population, affecting about one in 2500 newborns [1]. This autosomal
recessive condition affects mostly secretory organs, such as the pancreas,
liver and lungs. CF is caused by mutations in the Cystic Fibrosis Transmem-
brane Regulator (CFTR) gene, whose protein product is involved in the trans-
port of chloride ions across the apical membrane of epithelial and blood cells.
Loss of CFTR protein function causes thickened extracellular mucus to accu-
mulate, which impairs mucociliary clearance in the airways. CF prominently
leads to microbial pathogen colonization in the lung, followed by recurrent pul-
monary infection and chronic inflammation. Treatment options exist, includ-
ing mechanical and enzymatic mobilization of mucus, drug therapy to improve
residual CFTR function [2], antibiotics therapy to reduce pathogen load, anti-
inflammatory drugs, and lung transplantations. Nevertheless, for the majority of
patients the condition leads to progressive pulmonary damage, and eventually
respiratory failure and death.
CF lungs are colonized by a number of pathogenic bacteria, commonly in-
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cluding Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus in-
fluenza and Burkholderia cepacia [3]. While prompt and aggressive antibiotic
therapies can often control infections, prolonged antibiotic treatments may fa-
vor the emergence of antibiotic resistances, and can facilitate colonization by
multidrug resistant pathogens such as Achromobacter xylosoxidans and Steno-
trophomonas maltophilia [4], [5]. Currently, culture-based techniques are rou-
tinely employed to identify and classify lung pathogens, often using selective
culture media designed for specific groups of pathogens [6]. However, the cul-
ture conditions and procedures are necessarily biased towards known, previ-
ously encountered pathogens - whereas novel, slow-growing or rare microbes
might potentially be missed (e.g. atypical mycobacteria). Meanwhile, the tax-
onomic identification of observed pathogens often has limited resolution, and
the physiology and resistance profiles of the colonies are not backed up using
genomic information. Lastly, the background community opportunistic or ac-
cidental members of the lung microbiome is not routinely studied for clinical
use, despite its potential to harbor antibiotics resistance genes and to elicit or
modulate immune responses.
Culture-independent, genomic sequencing techniques offer potential alter-
natives for identifying pathogens and opportunistic colonizers, and for guiding
therapeutic decision-making. However, such methods are not routinely applied
for CF management, with the exception of PCR-based surveys of the 16S ribo-
somal RNA gene [7], [8], which are of limited taxonomic and functional resolu-
tion. Here, we develop a pragmatic approach that aims to maximize molecular
information, while minimizing patient discomfort and risk exposure. To achieve
this, we sequence DNA from non-invasive sputum samples, without prior re-
moval of host DNA and without complex enrichment- or depletion-protocols.
Forgoing host DNA depletion yields a substantial fraction of sequence reads
that are of human origin, and there will be contamination from the upper res-
piratory tract and mouth, but the simplicity of the approach has the unique ad-
vantage of providing an unbiased, comprehensive and reproducible set of reads
from the deep lung as well. For the current study, we collected and sequenced
sputum samples from the following categories: adult and pediatric CF patients,
Chronic Obstructive Pulmonary Disease (COPD) patients, and healthy individ-
uals. Using whole genome shotgun sequencing, we observed several known
pulmonary pathogens whose genome coverage routinely exceeded 95%, al-
lowing us to type the strains with very high precision using existing multi-locus
sequence typing (MLST) databases. Patient-specific differences from reference
strains are noted and discussed. Using the work flow we established, a de-
tailed genomic profile can be generated for any dominant pathogen in the lung,
including also potentially unknown pathogens.
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Figure 4.1: Sputum metagenomics workflow. a. Overview of the procedure. b.
Concentration of extractable DNA in sputum, across subject groups. c. Frac-
tion of non-human DNA sequence reads across subject groups. d. Fraction of
DNA sequence reads of a representative healthy sample, further broken down
according to taxonomic assignability to the assembled nucleotides from non-
human fraction. e. Taxonomic composition of all taxonomically assignable,
non-human sequences, at genus level (for each of the control groups, only one
representative sample is shown). All genera constituting at least 4.5% of the
annotated fraction in each sample are assigned a color code
4.3 Results and discussion
Sputum samples contain diagnostically useful DNA
We collected sputum samples from a total of 17 subjects: six CF patients,
four patients with COPD, and seven healthy controls (three smokers, four non-
smokers). We extracted the total DNA from each sputum sample and se-
quenced it without removal of human DNA, using the Illumina HiSeq 2000 plat-
form, Figure 4.1A. In total, the average sequencing depth was around 30 mil-
lion read pairs per sample (refer Figure 7.1). We then separated and quanti-
fied human and non-human read pairs; the latter were further assembled into
contigs and annotated using homology-based searches (section 4.5). The ob-
served DNA concentrations in sputum varied across subject groups, with CF
and COPD patients presenting on average higher DNA concentrations than the
healthy controls, Figure 4.1B. This observation agrees with previous studies
which suggested that disintegrating inflammatory cells such as neutrophils re-
lease high concentrations of host DNA into CF and COPD sputum, leading to
an increased sputum viscosity [9]. The observed higher DNA concentrations in
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the disease groups were thus likely due to lung inflammation. Correspondingly,
a large fraction of sequenced DNA (>90%) was of human origin, Figure 4.1C.
Conversely, healthy subjects produced smaller volumes of sputum with lower
DNA concentrations, and their residual DNA was also mostly of human origin
(refer Figure 7.2).
Lung microbiota composition varies strongly across individ-
uals
After limited (conservative) assembly of the non-human sequence fraction into
contigs, approximately half of the assembled nucleotides could be assigned a
taxonomic identity through homology searches, irrespective of subject groups
(Figure 4.1D). For healthy subjects, we found an overall higher diversity (aver-
age Shannon entropy of 3.07 in healthy non-smoker lungs, versus 1.08 in the
CF lungs, p< 0.038). Interestingly, the diversity was found to be reduced not
only in the sputum of CF and COPD, but also to some extent in smokers (re-
fer Figure 7.3). The most abundant taxa in healthy subjects were Prevotella,
Streptococcus, Veilonella, Haemophilus and Neisseria (Figure 4.1E). Previous
studies have indicated that the healthy lung does not harbor a stable and spe-
cific microbiome, but rather a mixture of microbes from the upper respiratory
tract and oral cavity [10]-[13]. In agreement, many of the microbes we identified
in healthy subjects corresponded to known oral (and occasionally also gastroin-
testinal or vaginal) flora.
In contrast, the microbiome composition in CF subjects was highly variable
and distinct from standard oral microbiomes. Each patient harbored a unique
and atypical community, often dominated by one or a few principle coloniz-
ers/pathogens such as Pseudomonas, Staphylococcus, Stenotrophomonas, or
Achromobacter, (Figure 4.1E and Figure 7.4). Compositionally, the CF flora
only marginally overlapped with those of the healthy and smoker populations.
Observed microbiota in CF subjects match clinical diagnosis
For five of the six CF subjects, all bacterial pathogens identified in the clini-
cal culture diagnosis were also identified through the DNA sequencing, each
with at least 10000 bp mapped to their genome (refer Table 7.1). For example,
we confirmed the presence of the typical CF pathogens Achromobacter and
Staphylococcus in the sample CF-85, despite ongoing antibiotic therapy. In this
particular patient we also observed multiple instances of antibiotic resistance
genes, including genes annotated to diminish effectiveness of the ongoing treat-
ment (see below, Prediction of antibiotic resistances and fitness-conferring mu-
tations). We also observed commensals such as Prevotella, Neisseria, Strep-
tococcus and Haemophilus in lower abundances. Similarly, we detected Pseu-
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domonas, a multidrug-resistant (MDR) Stenotrophomonas, and several other
common microbial inhabitants in pediatric CF patient CF-00, despite ongoing
antibiotic treatment. In contrast, the microbiomes of adult CF patients CF-82
and CF-76 were each primarily dominated by a single pathogen, Pseudomonas,
with very low relative abundances of Streptococcus.
Patients CF-99 and CF-94 exhibited a microbial community largely domi-
nated by Staphylococcus and Streptococcus respectively. Lack of a diverse
microbial community was likely due to ongoing antibiotics treatment for patients
CF-94 and CF-99 at the time of sample collection (Table 7.2 and Table 7.3 -
7.8 ); in this case, no resistances against the administered antibiotics had been
detected in clinical testing. The use of antibiotics is known to correlate inversely
with diversity and to instigate significant changes in bacterial community struc-
ture, especially in younger patients that harbor a relatively rich and susceptible
microbial community [14], [15] as compared to older patients that often develop
resilient communities [16], [17].
Samples from COPD patients reveal intermediate microbial
complexity
We analyzed the microbiome diversity for each COPD patient and found that,
of the four samples collected, CD-47 had the largest and most diverse pop-
ulation, closely resembling the composition of a healthy microbiome. Subject
CD-34 was unique in that it was the sole sample in which we detected signifi-
cant amounts of a virus, Herpes simplex virus. This virus was covered deeply
enough to be partially assembled, and was seen against a background of Strep-
tococcus, Rothia and Haemophilus with Fusobacterium and Prevotella greatly
reduced (Figure 7.4). Overall, samples from COPD patients were somewhat
more difficult to characterize. On several occasions we failed to detect eukary-
otic genera that had been observed in the clinical culture-based diagnostics.
For example, in patient CD-42 we were able to reliably detect the presence of
several bacterial community members (confirmed by clinical microscopy results)
but were unable to confirm the presence of Candida. Since eukaryotic genomes
tend to be larger and more challenging to assemble, they may sometimes fail to
be detected in sufficient numbers in our approach.
Entropy landscapes allow the detection of clonally expanded
pathogens
The microbial community in the sputum of CF patients is expected to be heavily
skewed a small number of entrenched, chronic pathogens stand out against a
more diverse background of contaminants and putatively harmless colonizers
[18], [19]. We devised a three-dimensional binning strategy adapted to this sit-
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uation, in which each contig is assessed in terms of i) GC-content as a proxy
for broad taxonomic identity, ii) length as a proxy for assembly depth, and iii)
sequence homogeneity within the assembly as a proxy for clonality. The latter
measure is expressed as entropy, where a small entropy value reflects a low
number of mismatched sites in the assembly of a given contig. Low-entropy
contigs should reflect clonal or near-clonal microbial strains (within the limits
set by sequencing accuracy and depth). We used these three measures to vi-
sualize the entire non-human sequencing result of any patient of interest in a
three-dimensional binning plot (Figure 4.2). For those contigs whose taxonomic
identity could be confidently inferred, we additionally used a color code to high-
light groups of sequences that might putatively belong to the same genus.
In Figure 4.2, entropy landscapes are used to visualize the lung community
composition of two CF patients with distinct dominant pathogens, as well as
one representative sample each from COPD, smoker and non-smoker groups.
For CF-00, the plot shows two likely clonal overgrowths with distinct GC content
(Figure 4.2A), suggesting chronic infections by two distinct pathogen species.
Indeed, annotation revealed these contig groups to consist exclusively of mem-
bers of the genera Stenotrophomonas and Haemophilus, respectively (Figure
4.2B).
These observed landscapes are characteristic of microbial communities with
one or a few dominant members that have grown clonally to occupy a sizeable
proportion of their niche. In contrast, the healthy and smoker groups gener-
ally were not dominated by few clonal species, as reflected in the absence of
clustered low-entropy contigs (see Figure 7.5−7.8 for plots of each subject sam-
pled).
The entropy landscapes allow the visual separation of likely oral contam-
inants and low-abundance colonizers from the clonal pathogen(s) growing
chronically. Furthermore, any non-annotated contigs that visually cluster within
the pathogen contigs may indicate undocumented genomic regions, which
would have been recently introduced into the pathogen genome and may not
be known from reference strains in databases. Hypothetically, even atypical
pathogens that are not yet annotated in any database would become discern-
able, although we have not encountered such a case among our samples.
Multi locus sequence typing of pathogens using unbiased
sputum sequences
Multi Locus Sequence Typing (MLST) is a well-established method to charac-
terize isolates of a given microbial species in the context of previously observed
strains of that species, via DNA sequencing of a limited, pre-defined group of
diagnostic genes [20]. Traditional MLST requires the isolation and culture of
microbes of interest, followed by specific PCR assays targeting the genes used
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Figure 4.2: Pathogen overgrowth can be separated from background diversity.
Sequence contig feature plots, depicting at least one sample from every subject
group. Each data point represents an assembled contig, with colors correspond-
ing to genus level taxonomy annotations. The three axes show contig length (X-
axis), contig sequence heterogeneity (entropy, Y-axis) and GC-content (Z-axis).
a. Magnified view of the plot of patient CF-00 without taxonomic annotation. b.
same plot (CF-00), but with taxonomic annotation. c. Representative plots of
one subject from each group. Throughout, genera constituting less than 5% of
the annotated fraction, as well as un-annotated contigs, are shown in grey color.
for strain typing. In contrast, by using WGS sequencing data we omit these
steps and directly proceed to characterizing strains of interest from the mixture.
Importantly, there is no need to decide, ahead of the experiment, which strains
are to be typed since no specific PCR is required. As long as a species or
genus has been previously subjected to MLST genotyping (i.e., a well popu-
lated MLST database with corresponding marker genes is available), it can be
characterized. In the following, we describe two examples of MLST strain geno-
typing in the sputum of CF patients one yielding a previously observed strain
from a well-sampled strain collection, the other yielding a more exotic strain for
which even the exact species designation remains unclear (it may belong to a
new, as yet un-named species).
We characterized a strain of Stenotrophomonas maltophilia which we had
observed in the sputum of patient CF-00. S. maltophilia is an intrinsically multi-
drug-resistant (MDR) opportunistic pathogen that has been isolated from sev-
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eral water-associated environments inside and outside of hospital premises
[21]. Like many free-living opportunistic pathogens, it possesses a large and
versatile genome that allows it to colonize diverse environments and degrade
toxic compounds such as antibiotics, even using them as a food sources [22].
S. maltophilia exhibits high levels of genetic diversity, making it hard to precisely
track the source of infections and distribution of isolates in hospitals. We per-
formed MLST using a standard set of seven house-keeping genes [23], all of
which were found with 100% sequence coverage in our sample. We observed
that the patient harbored a single strain (likely from a single infection event),
which was 100% identical to a strain encountered previously, in a CF case in
the UK. We placed this strain, together with other strains observed previously, in
a phylogenetic tree constructed from the MLST alignment, see Figure 4.3. The
tree was then annotated with the sampling origin of each strain: clinical, environ-
mental, hospital environment, or animal-associated. The phylogenetic analysis
revealed a clear clustering of clinically obtained strains in a single clade, sug-
gestive of specialization and frequent transfers from patient to patient. Overall,
we found this genome to be very well recovered from the sputum, with an anal-
ysis using CheckM [24] reporting it to be 97.2% complete.
Next, we observed and characterized a putative Achromobacter strain from
patient CF-85. Members of the Achromobacter genus form a group of gram
negative, strictly aerobic, motile bacteria of which more than 10 species are
currently known. The majority of strains isolated from CF patients belong to the
species A. xylosoxidans, which is also an intrinsically multidrug-resistant oppor-
tunistic pathogen [25]. Outside of patients, strains can also be found in a vari-
ety of aquatic environments ranging from moist soils to dialysis solutions [26].
Achromobacter infections have been generally observed in older patients with
pulmonary diseases, but their implication in deteriorating lung function has re-
mained unclear [27], [28]. Accurate identification and discrimination of different
Achromobacter species has been a challenging task due to limited taxonomic
delineation. A recent study revealed that several commercial test systems used
in different diagnostic laboratories were unable to distinguish different Achro-
mobacter species infecting CF patients, and would often identify them incor-
rectly as A. xylosoxidans [29].
Using the appropriate gene set for this genus, we again performed MLST.
In this case, we did not find any matches to previously documented strains.
Instead, we placed our sequences on a phylogenetic tree encompassing the
entire genus, constructed using concatenated housekeeping genes from all
species and type strains available in the PUBMLST database (http://www.
pubmlst.org/smaltophilia/) [30], see (Figure 4.4 and methods). Our ob-
served strain did not cluster with other identified strains, with the exception of a
single unnamed and uncharacterized isolate from another CF case. The closest
neighbors of these two strains in the tree were A. marplatensis and A. pulmo-
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Figure 4.3: Strain typing of S. maltophilia strain from sputum sample of CF-
00. Yellow color highlights the phylogenetic position of the strain observed in
this study, relative to previously typed strains deposited in MLST databases.
Isolation sources of database strains are shown color-coded.
nis. Although routine clinical analysis using microscopy had identified the strain
as A. xylosoxidans, our phylogenetic analysis suggested otherwise; the two se-
quences were sufficiently removed from A. xylosoxidans to suggest a novel but
previously unidentified clade. Independent studies [31] have also provided evi-
dence to support the presence of as-yet unnamed and uncharacterized species
in the Achromobacter genus, responsible for CF infections in patients. Further
species divisions in this clinically relevant but under-sampled genus are needed,
and patient-derived genomes such as ours might provide valuable context.
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Figure 4.4: Strain typing for an Achromobacter isolate present in CF-85. No
close relatives have been observed for this isolate (the strain likely does not
belong to a named species). All monophyletic clades with 95% members from
a single species have been collapsed.
Prediction of antibiotic resistances and fitness-conferring
mutations
Chronic colonizers can adapt to their host environment to sustain themselves
under varying selection pressures, such as antibiotic treatments or the pres-
ence of potentially competing co-infections. This is particularly problematic in
the case of infections caused by antibiotic-resistant bacteria in CF patients. For
example, a five-fold increase in MRSA infections has been observed in the past
15 years [32], and 18.1% of P. aeruginosa infections in a population of primar-
ily young adult CF patients were reported to be MDR [32]. These pathogens
acquire various resistance mechanisms to therapeutic agents including altered
membrane permeability, efflux pumps or induced enzymatic modifications. Iso-
lates with identical resistance patterns sometimes exhibit different genetic mod-
ifications, indicating that these bacteria can use distinct strategies to respond to
similar environmental pressures [33].
To test whether sputum sequencing might help to guide antibiotic treatment,
we screened for the presence of putative resistance-conferring genes and alle-
les. We compared all predicted open reading frames in each sample against a
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database of known and annotated antibiotic resistance genes (see Methods),
employing conservative similarity cutoffs. For example, in the sputum of CF-85,
we identified genes encoding for class A beta lactamases, which are classified
as serine enzymes conferring resistance to penicillin. In the same sample, we
also identified a 23S ribosomal RNA methyltransferase, conferring varying de-
grees of resistance to macrolide, lincosamide and streptogramin b antibiotics,
see (Table 4.1 and Table 7.3 - 7.8).
Table 4.1: The Achromobacter strain isolated from patient CF-85 underwent
routine clinical testing for antibiotics sensitivity; the compounds tested and the
observed results are shown. This is contrasted with automated predictions
based on the gene content of the sputum sequence data.
The predictions were validated independently by clinical resistance reports,
where the majority of both resistant as well as non-resistant calls were con-
firmed (Table 4.2). False predictions were limited to false negatives, i.e., clini-
cally observed resistances which were not predicted based on sequence analy-
sis. Interestingly, we additionally observed a virulence gene, mprF, annotated as
providing resistance against naturally secreted antimicrobial peptides known as
defensins. These cationic peptides are largely secreted by neutrophils and by
the airway epithelium in the CF lungs to protect the epithelia against infections.
S. aureus strains with resistance to defensins show a greater pathogenic poten-
tial [34]. Thus, the presence of such virulence factors is of general relevance to
clinicians when designing treatments for CF patients.
Apart from antibiotics resistances, other phenotypes such as biofilm forma-
tion or exo-polysaccharide secretion may also be actively adapting in chronic
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Table 4.2: Prediction of antibiotics resistances. b. Summary table for all CF sub-
jects, indicating the overlap between the resistance predictions and the clinical
test results.
colonizers. Indeed, it is known that chronic colonizers develop considerable
genomic heterogeneity which is perhaps maintained by specialization or bal-
anced selection [35], [36]. Given the depth of sequencing used here, it is not
possible to study this heterogeneity quantitatively, but specific mutations of in-
terest can be tracked. For example, initial isolates of Pseudomonas aeruginosa
from CF patients are generally non-mucoid and responsive to antibiotics. How-
ever, during protracted infections, these pathogens start overproducing an exo-
polysaccharide known as alginate which is a polymer of -D-manuronic acid and
L-glucuronic acid [37], eventually leading to their transition into a mucoid phe-
notype. Mucoid P. aeruginosa are immune to several antibiotics and to phago-
cytosis [38]. Correspondingly, the mucoid phenotype is directly linked with poor
clinical outcome for patients. According to the clinical laboratory report, the
sputum of CF-82 harbored both mucoid and non-mucoid P. aeruginosa strains.
To better understand the underlying genetic modifications that lead to this phe-
notypic transition, we inspected the mucA gene, which encodes for a trans-
membrane -factor responsible for limiting expression of the 12 gene alginate
operon (algA-algD). Loss of function mutations in the mucA gene typically result
in production of alginate, in turn giving rise to a mucoid phenotype. In CF-82,
we indeed identified 11 sequence reads showing a single-nucleotide deletion
at position 429 in the mucA gene (Figure 4.5), leading to a truncated and pre-
sumably non-functional protein. In contrast, 7 reads supported the presence
of a non-mutated, fully functional protein. Since there was little heterogeneity
elsewhere in the genome, this is indeed suggestive of an ongoing adaptation.
Genome comparisons reveal patient-specific pathogen fea-
tures
The MLST procedure allowed us to precisely characterize the taxonomic iden-
tity of strains of interest, but provided little phenotypic information regarding
pathogenicity or metabolic characteristics. Moreover, this information is not rou-
tinely available from culture-independent techniques in the clinic. To address
55
Figure 4.5: Read alignment against a section of the mucA gene from Pseu-
domonas aeruginosa, from patient CF-82. 11 reads show a wild-type sequence
at this position, but 7 reads show a deletion event predicting a non-functional
protein and a corresponding shift from a non-mucoid to a mucoid phenotype in
this strain.
this, we collected all contigs assembled from CF-00 belonging to S. maltophilia,
and aligned them against two closely related clinical database strains, Sm
K279a and Sm ISSMS3 [genbank accession NC 010943 and NZ CP011010,
respectively] (Figure 7.9). This identified seven large-scale homologous re-
gions, see (Figure 4.6A). These regions were interspersed by non-homologous
intervals unique to each genome, including some in the assembled genome
from patient CF-00. The assembled genome also exhibited some genomic re-
arrangements with respect to the reference strains. We next made gene pre-
dictions for all the unique genomic regions of size 1kb or greater present in the
reconstructed genome. Interestingly, we found a large region of 23 genes (Fig-
ure 4.6B), 14 of which were found to code for a virulence-associated Type VI
Secretion System (T6SS). T6SS systems typically consist of a conserved clus-
ter of 13 core genes, 10 of which were observed in our gene set together with
4 additional non-conserved T6SS accessory genes (Figure 4.6C) responsible
for post-translational regulation based on orthology predictions. T6SS secre-
tion systems (Figure 4.6D) were first described a decade ago in Vibrio cholerae
[39] and since then have been studied in several gram-negative bacteria in-
cluding P. aeruginosa [40]. They allow the secretion of a range of substrates
such as toxins, adhesins, hydrolytic enzymes and effector proteins, and have
been classified into four subtypes [41]. T6SS have been associated with biofilm
formation, and antagonistic or bactericidal functions towards competing bacte-
rial species [40]. They are frequently observed in genomic islands and their
presence shows little correlation to bacterial taxonomy, suggesting that they are
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Figure 4.6: Pathogen genome comparisons reveal patient-specific additions.
Two public reference genomes of S. maltophilia are compared against assem-
bled contigs from patient CF-00. a. Genome wide alignment showing blocks
of colinearity, additions and deletions. White stretches indicate un-alignable,
unique regions in each genome. Vertical red lines separate individual assem-
bled contigs. b. Magnified view centered on a genomic region that is unique
to the strain in patient CF-00. Genes with homology to Type Six Secretion
Systems (T6SS) have been labeled with numerical IDs (see panel C below).
Genes marked with an Asterisk showed no detectable homology in sequence
databases. c. The core gene cluster of T6SS is depicted in yellow; additional
accessory T6SS genes which are also observed in patient CF-00 are colored
in grey. d. Schematic model of the T6SS protein structure based on present
knowledge.
frequently acquired through horizontal gene transfer [42].
In the past decade, T6SS have repeatedly been reported to be absent in all
S. maltophilia isolates, both in clinical and environmental isolates [43]-[45]. Its
presence in our clinical isolate thus highlights its outstanding ability to adapt to
new hosts and surroundings. In addition to our observation, recent observa-
tions in new S. maltophilia strains [46] were also supportive of T6SS systems
(although the genomes are yet to be published).
The spread of such virulent secretory systems in multidrug-resistant CF
pathogens provides a unique opportunity to identify new targets for designing
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innovative treatments. Anti-virulence drugs [47] that target specific secretion
systems to disarm the bacteria can be a likely alternative to conventional an-
tibiotics. Thus, whole genome reconstruction of highly abundant bacteria in the
patient samples provides an exclusive possibility to study idiosyncratic genomic
regions and to identify potential drug targets for targeted treatments.
4.4 Conclusions
In this study, we have introduced a culture-independent technique for charac-
terizing airway pathogens in the chronically inflamed lung, using routine non-
invasive sputum sampling coupled to unbiased WGS sequencing. Our approach
provides additional valuable information complementing routine culture-based
clinical microbiology results in the future. This could help to design tailored
treatment regimes by reducing the risk of ineffective treatment.
We find, firstly, that WGS sequencing can serve to describe the broad tax-
onomic composition of the lung microbiome, particularly when combined with
reference databases. Reference information for human-associated microbes is
growing at a remarkable pace [48], [49] and should make WGS-based taxo-
nomic classification ever more accurate in the future.
Secondly, various binning approaches [50] can be used to partially assemble
genomes of interest from the WGS data. In the case of chronic infections origi-
nating from one or a few clonal invasions, we find that contig-by-contig entropy
is a good measure for isolating pathogens from contaminants and the complex
colonizing background of microbes. Such an approach may help clinicians to
more precisely identify the disease-causing pathogen.
Thirdly, for those pathogens that have already been well studied in molecu-
lar terms, we demonstrated that MLST can be applied directly using WGS data.
This allows the exact strain identity to be established, leveraging the power of
MLST databases and catalogued strain observations. Importantly, this can sig-
nificantly simplify the process of tracing infection outbreaks at clinics using un-
targeted, retrospective data.
Lastly, the partially assembled genomes and the remaining, unassembled
contigs can be informative with regard to the expected efficacy of treatment
options. We find that while antibiotics resistance prediction are substantially
supported by confirmatory clinical tests, they are not yet entirely error free. This
is likely to improve with better data curation in the resistance databases, but
the most challenging resistances to predict correctly will be those that arise
from specific mutations in normal, cellular genes [51]. Importantly, aside from
predicting resistances, WGS data may guide the decision as to which antibiotics
to include in clinical testing in the first place, particularly for second-generation
antibiotics designed to counteract or circumvent known resistances.
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Overall, WGS sequencing of sputum may become one of the building blocks
supporting the advancement of a more personalized medicine. It yields not
only deep insights into the lung microbiome by allowing an unbiased metage-
nomic dissection of microbial pathogens, but also enables analysis of human
genomic DNA for host genotyping (e.g. for host susceptibility to infection or for
unexpected treatment responses). For routine tracking, deep WGS sequencing
could be alternated with more shallow survey sequencing or 16S sequencing;
the latter are likely sufficient to quantify changes in community composition, with
deep sequencing only necessary when new pathogens invade.
4.5 Methods
Sputum samples and DNA extraction
Sputum was either produced spontaneously (in the case of CF and COPD pa-
tients), or after induction by hypertonic saline nebulization (in the case of healthy
control subjects). The sampling was conducted at the Cantonal Hospital St.
Gallen and at the Childrens Hospital of Eastern Switzerland. Healthy control
subjects were free of symptoms of respiratory discomfort and did not show overt
infections. All study participants provided informed consent. The study was
approved by the cantonal ethical committee St. Gallen (EKSG 13/112). The
sputum samples were weighed and aliquoted into sterile tubes. After dilution in
Sputolysin (Calbiochem Corp, San Diego, CA, USA), total DNA was extracted
using the High Pure PCR template preparation kit (Roche, Basel, Switzerland)
according to the manufacturers instructions. DNA concentration was measured
using the ACTgene UV99 spectro-photometer at a wavelength of 260nm, and
samples were stored at 20◦C.
Whole genome shotgun sequencing
The TruSeq DNA Sample Prep Kit v2 (Illumina Inc, California, USA) was used
for library generation. The quality and quantity of the enriched libraries were val-
idated using a Qubit (1.0) fluorometer and the Caliper GX LabChip GX (Caliper
Life Sciences, Inc., USA). The libraries were normalized to 10nM in Tris-Cl 10
mM, pH8.5 with 0.1% Tween 20. The TruSeq PE Cluster Kit v3-cBot-HS (Illu-
mina, Inc, California, USA) was used for cluster generation using 2 pM of pooled
normalized libraries on the cBOT. Paired-end sequencing was performed on the
Illumina HiSeq 2000 at 2 x 101 bp using the TruSeq SBS Kit v3-HS (Illumina,
Inc, California, USA). Reads were quality-checked with FastQC [52].
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Removal of the host genome and assembly
We used Bowtie2 [53] to align the paired-end reads against the human refer-
ence genome, assembly Hg19 [54]. Read pairs were omitted from any fur-
ther downstream analysis if one or both mates from the pair aligned to the hu-
man genome. We assembled contigs from the remaining read pairs using the
Spades assembler [55] under the only assembly setting.
Taxonomic annotation and diversity estimation
We searched the contigs against the NCBI nucleotide database using Blastn
[56] with an e-value cutoff of e−15. The most common recent ancestor of all ge-
nomic sequences that aligned to a given contig with a bit-score within ten per-
cent range of the highest scoring alignment was used to taxonomically annotate
the contig. We discarded all contigs with annotations belonging to the metazoan
kingdom, to further remove host genome sequences from further downstream
analysis. We used nucleotide counts from assembled contigs with genus level
taxonomic assignments to calculate Shannon entropy as a measure of diver-
sity. We used Mann Whitney U tests for significance testing and subsequently
adjusted the p-values using the Bonferroni correction for multiple testing.
Contig binning via entropy landscapes
We recruited all paired-end reads that had contributed to the assembly process
back against the non-human contigs using Bowtie2. This recruitment was used
to calculate the average number of mismatches and gaps over the length of
the contig (entropy). This score was depicted on the z-axis of the microbial
landscape plots, together with contig length on the x-axis, and GC content on
the y-axis. Contigs from genera constituting more than 5% of the annotated non-
human contigs were color-coded according to their annotation. We depicted the
un-annotated and the remaining contigs from the low abundance genera in a
single color.
MLST and phylogenetic placement of abundant clonal
species
We constructed a maximum likelihood tree for Stenotrophomonas maltophilia
using RaxML [57] under the GTRCAT model, with 1000 bootstraps, using the
concatenated sequence composed of the seven house-keeping genes atpD,
gapA, guaA, mutM, nuoD, ppsA and recA. In patient CF-00, these genes
showed 100% identity over their entire length to a previously observed strain.
All the sequences of the previously typed strains used for building the tree were
downloaded from http://pubmlst.org/smaltophilia/. The tree was rooted using
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Xanthomonas Campestris 8004, [genbank accession NC 007086.1] as an out-
group. For the Achromobacter genus, we built another phylogenetic tree us-
ing the concatenated sequences of the seven house-keeping genes eno, gltB,
lepA, nrdA, nuoL, nusA and rpoB. Full-length sequences of all seven genes
were recovered from the assembled contigs of the patient CF-85. There was
no exact match found to any previously documented strain. The sequences
of previously typed strains used for building the tree were downloaded from
http://pubmlst.org/achromobacter. The tree was rooted using Bordetella
pertussis [genbank accession LN849008] as an out-group.
Identification of antibiotic resistance genes and cassettes
We used the comprehensive antibiotic resistance database [58] to search for
resistance-conferring genes in our samples. The results from the web server
were filtered to include only matches with over 90 amino acid length and over
90% identity. We further compared these findings with the clinical laboratory
reports on observed antibiotics resistances.
Genome alignment
We used Mauve [59] for ordering the assembled Stenotrophomonas con-
tigs from CF-00 and performing whole genome alignments against reference
strains.
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Chapter 5
Pathogens and host immunity in
the ancient human oral cavity
As a part of this project, I was responsible for the analysis of whole metagenome
shotgun sequence data collected from dental calculus of two samples G12 and
B61 recovered from an excavation led by Dr. Warinner at an approximately 1000
year old burial site in Dalheim, Northern Germany. The aim of this study was to
reconstruct health and dietary histories of the ancient individuals using a com-
bination of 16S rRNA and WGS metagenomic, metaproteomic and microscopy
based analysis. The list of my contributions is as follows.
1. Relative proportions of different bacteria, viruses, archea and fungi were
estimated using the assembled whole metagenome sequencing data and
a high confidence taxa list of all the identified microbes was prepared.
2. Using gene based evidence, 40 opportunistic pathogens were identified
as inhabitants of the oral microbial community.
3. Virulence and drug resistance associated genes were identified to func-
tionally characterize the metagenome of the ancient oral community.
4. Near complete whole genome reconstruction of a periodontitis pathogen
Tanerella forsythia was carried out and subsequently analyzed for the
presence of house keeping and virulence associated genes. Two
pathogenicity associated islands were found to be missing that are present
in the contemporary reference genome.
5. 100 whole metagenome shotgun datasets from contemporary plaque
samples were analyzed to draw comparisons with the findings from an-
cient dental calculus.
Minor contributions include
1. Aided in construction of in house proteomic database and annotating of
proteomic datasets using homology based approaches.
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2. Assisted in identification of sequences with possible dietary origin using
phylogenetic analysis
Summary
Dental Calculus, a calcified form of dental plaque is of great interest to arche-
ologists since it offers a unique opportunity to examine the life style of ancient
individuals. As plaque is accumulated over an entire life time in the absence
of dental hygiene practices, it entraps debris from the oral and upper respira-
tory microbes (that would occasionally get coughed up in the oral cavity) and
food particles. This information is sealed when the dental plaque calcifies post
mortem to form a hard, impervious coat that preserves extremely well for over
several centuries. In the current study, molecular sequencing techniques and
microscopy has been used to investigate the impact of oral microbes on the
health of ancient individuals. Several commensal and pathogenic microbes im-
plicated in oral respiratory and cardiovascular diseases have been successfully
identified. Genomic evidence indicating that the oral cavity has long been a
reservoir for putative resistance genes was found and a near complete genome
of a red complex periodontitis pathogen was reconstructed with missing ge-
nomic pathogenicity islands. Lastly, DNA sequences of plant and animal origin
were identified providing clues about ancient dietary practices.
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Unlike other human microbiomes, the oral microbiome will cause 
disease in a majority of people during their lifetime, suggesting that it 
is currently in a state of dysbiosis rather than symbiosis1,2. The human 
oral microbiome comprises more than 2,000 bacterial taxa, including 
a large number of opportunistic pathogens involved in periodontal, 
respiratory, cardiovascular and systemic diseases3–7. Dental calculus, a 
complex, calcified bacterial biofilm formed from dental plaque, saliva 
and gingival crevicular fluid8, is emerging as a potential substrate for 
the direct investigation of the evolution of the oral microbiome and 
associated measures of oral health and diet9,10. Recently, a DNA-based 
16S rRNA phylotyping study identified the major bacterial phyla in 
dental calculus and argued for shifts in microbial diversity associated 
with the origins of agriculture and industrialization11, and, so far, five 
common oral bacteria have been identified in historic and prehistoric 
dental calculus using targeted PCR12, quantitative PCR (qPCR)11 
and immunohistochemistry13. However, phylum-level community 
analysis and single-species targeted amplification are insufficient to 
characterize oral health and disease states, as this requires a deeper 
taxonomic and functional understanding of microbiome ecology14.
We present the first detailed analysis to our knowledge of ancient oral 
microbiome ecology and function at the genus and species levels, leading 
to a deeper understanding of recent evolution of the human oral microbi-
ome. Focusing on the dental tissues of four adult human skeletons (G12, 
B17, B61 and B78) with evidence of mild to severe periodontal disease 
from the medieval monastic site of Dalheim, Germany (c. 950–1200 CE) 
(Supplementary Fig. 1), as well as modern dental calculus from nine 
individuals with known dental histories, we demonstrate for the first time, 
to our knowledge, that the human oral microbiome has long served as a 
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reservoir for a broad suite of opportunistic pathogens implicated in both 
local and systemic disease and harbored a diverse range of putative anti-
biotic resistance genes. We confirm the long-term role of host immune 
activity and red complex pathogen virulence in periodontal pathogenesis, 
despite major changes in lifestyle, hygiene and diet over the past millen-
nium. We reconstruct the genome of a major periodontal pathogen and 
present the first evidence, to our knowledge, of dietary biomolecules to 
be recovered from ancient dental calculus. Finally, we further validate our 
findings by applying multiple microscopic, genetic and proteomic analy-
ses in parallel, providing a systematic biomolecular evaluation of ancient 
dental calculus preservation, taphonomy and contamination.
RESULTS
The	ancient	oral	microbiome
Applying shotgun DNA sequencing to dental calculus for the first 
time, we found that it was strongly dominated by bacterial DNA, with 
minor contributions from human, viral, dietary and fungal sources 
(Fig. 1a). Using both targeted and shotgun 16S rRNA sequences 
(n = 509,067), we identified a total of 2,699 microbial operational 
taxonomic units (OTUs) in the ancient dental calculus, with the 100 
most abundant taxa accounting for 86.6% of the total reads (Fig. 1b 
and Supplementary Fig. 2). One archaeal and nine bacterial phyla 
were dominant in ancient dental calculus (Supplementary Table 1): 
Firmicutes (49.5 ± 10.6%), Actinobacteria (12.0 ± 6.1%), Proteobacteria 
(11.5 ± 8.6%), Bacteroidetes (6.6 ± 3.6%), TM7 (4.6 ± 4.0%), 
Synergistetes (3.3 ± 2.6%), Chloroflexi (2.7 ± 1.5%), Fusobacteria (2.1 ± 
1.8%), Spirochetes (0.6 ± 0.3%) and Euryarchaeota (0.4 ± 0.6%), all 
of which are also dominant in the human oral microbiome today4. 
Notably rare in ancient dental calculus was Acidobacteria, a ubiqui-
tous and abundant bacterial phylum in soil15.
To address biases resulting from the sequencing approach and the 
16S rRNA gene hypervariable region (V3, V5, V6) primer choice 
(Supplementary Fig. 3), we visualized evidence for each OTU sepa-
rately for each targeted and shotgun 16S rRNA detection method, as 
well as for shotgun metagenomic and metaproteomic data (Fig. 1b). 
Most OTUs were detected using multiple methods. OTUs detected 
from targeted V3 and shotgun data generally showed good agree-
ment, whereas V5 and V6 primers showed clear evidence of primer 
bias and OTU dropout. Shotgun metagenomic data showed excel-
lent agreement with consensus 16S rRNA OTUs when reference 
genomes were available. Shotgun metaproteomic data also showed 
good agreement with the OTUs identified on the basis of genetic 
data, and agreement is expected to improve as protein databases 
grow to include more predicted proteins and epigenetic variants. 
Because ancient DNA and proteins undergo different taphonomic 
processes and have different contamination risks, the high degree of 
phylogenetic consensus observed for data generated from independ-
ent extractions, using different methods and targeting different bio-
molecular types, demonstrates that an endogenous oral microbiome 
can be robustly and reliably recovered from ancient dental calculus.
Carriage	of	specific	pathogens
The normal human oral flora includes a large number of endogenous 
cariogenic, periodontal and other opportunistic pathogens. Although 
these taxa generally do not cause extraoral disease in healthy subjects, 
they nevertheless pose a serious risk for the elderly and immunocom-
promised16,17 and are known to be involved in the etiology of chronic 
systemic diseases, including cardiovascular disease18. As the detection 
of particular species from metagenomic sequence data is an open area 
of research, we applied a conservative contig assembly and BLAST 
strategy and screened our results against the Pathosystems Resource 
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Figure 1 Taxonomic and phylogenetic characterization of ancient dental 
calculus. (a) Relative proportions of bacterial, archaeal, eukaryotic and viral 
DNA in ancient calculus estimated from assembled whole-metagenome 
shotgun sequences of two individuals. (b) Phylogenetic tree of the 100 
most abundant OTUs in ancient dental calculus samples from 4 pooled 
individuals. Evidence for the presence and abundance of each microbial OTU 
is represented by colored, size-scaled circles for each targeted 16S rRNA 
hypervariable region (V3, V5, V6), shotgun 16S rRNA sequences (S) and other 
genes (G) and proteins (P) assigned to that OTU. OTUs for which no reference 
genome exists or for which insufficient proteome data have been validated for 
inclusion in the protein search databases are marked with gray squares, as no 
hits could be matched to those OTUs. The tree scale bar indicates nucleotide 
substitutions per site. Relative phylum abundance (normalized mean of 
all genetic data generated from 16S rRNA sequences) is represented by a 
column chart showing the phyla represented in the top 100 OTUs (colored), 
remaining phyla (dark gray) and unidentified OTUs (light gray).
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Integration Center (PATRIC) database19 to 
identify 40 putative opportunistic patho-
gens in ancient dental calculus (Table 1), of 
which only 5 had been previously reported 
in ancient samples11–13. We also identified 
phage DNA sequences specific to particular 
bacteria (Table 1), including Streptococcus 
mitis phage SM1, which has been previously 
shown to mediate S. mitis attachment to 
platelets and to increase bacterial virulence 
in the endocardium20.
Both DNA and proteins from the perio-
dontal pathogens T. forsythia, Porphyromonas 
gingivalis and Treponema denticola were 
particularly abundant in our ancient den-
tal calculus samples, demonstrating that 
these so-called red complex bacteria21 were 
strongly associated with periodontal disease 
during the medieval period, just as they are 
today, despite substantial changes in oral 
hygiene, diet and lifestyle. Additionally, 
all three of these pathogens were found 
at substantially higher frequency in our 
ancient dental calculus samples than in 
the Human Microbiome Project (HMP)3 
healthy cohort (Supplementary Fig. 4a–c  
and Supplementary Table 2), consistent with 
expectations for periodontal disease. We 
also identified several oral taxa (for exam-
ple, Aggregatibacter actinomycetemcomitans, 
Streptococcus mutans and S. mitis) that have 
been shown to cause bacteremia and infec-
tive endocarditis7,18, demonstrating that the 
human oral microbiome has long harbored 
pathogens that contribute to risk of cardio-
vascular disease. Additional pathogens 
included those implicated in acute dental 
infections (for example, Actinomyces odonto-
lyticus), caries (S. mutans) and opportunistic 
upper and lower respiratory illness (for exam-
ple, Streptococcus pneumoniae, Streptococcus 
pyogenes and Haemophilus influenzae). Of 
interest, all ancient dental calculus samples 
were also found to contain disordered carbon 
(microcharcoal), a respiratory irritant. Two 
obligate human taxa, Neisseria meningitidis 
and Neisseria gonorrhoeae, causative agents of 
bacterial meningitis and gonorrhea, respec-
tively, were also observed. N. meningitidis 
and N. gonorrhoeae form a recently diverged 
pathogenic clade of Neisseria, a genus comprising many commensal 
species inhabiting the mucosa and dental surfaces of animals22, and 
both are prevalent members of the human oral microbiome. Genital 
N. gonorrhoeae strains can infect the pharynx and engage in genetic 
exchange with other Neisseria species;23 however, oral strains are 
not known to cause genital infection. Oral N. meningitidis is a lead-
ing cause of bacterial meningitis, although disease susceptibility is 
determined by a combination of host genetics and strain virulence24. 
Finally, we observed two additional oral taxa present at substantially 
higher frequency in at least one ancient dental calculus sample com-
pared to the HMP healthy cohort: Filifactor alocis and Olsenella uli 
(Supplementary Fig. 4e,f). Although not classified as pathogens in 
the PATRIC database, these bacteria have recently been associated 
with periodontitis and endodontic infections, respectively25,26.
Virulence
To further characterize the pathogens detected in ancient human 
dental calculus, we compared information on the functional features 
of putative genes and proteins associated with virulence, drug resist-
ance, plasmids, transposons and phages to the information available 
in NCBI records. Although not exhaustive, a preliminary list of well-
supported virulence-associated genes and proteins was compiled 
table 1 Putative pathogens identified from assembled metagenomic and metaproteomic 
sequences in ancient dental calculus
Pathogensa
Genes  
(contigs)
Proteins  
(peptides) Virulence
Drug  
resistanceb Plasmid
CTn or 
phage
Actinomyces odontolyticus c 3 (4) 3 (34)
Aggregatibacter  
 actinomycetemcomitans
50 (68) 0 + +
Campylobacter concisus 10 (20) 0 +
Campylobacter curvus 12 (11) 0
Campylobacter rectus c 3 (9) 3 (15) ++
Campylobacter showae c 3 (13) 1 (2)
Capnocytophaga gingivalis c 2 (11) 3 (7) +
Capnocytophaga ochracea 938 (4,909) 0 + + + +
Capnocytophaga sputigena c 2 (2) 0 +
Clostridium difficile d,e 30 (76) 0 + +
Corynebacterium matruchotii c 2 (15) 12 (89)
Eikenella corrodens c 11 (38) 2 (11) +
Fusobacterium nucleatum 656 (1,525) 4 (21) ++ + + +
Fusobacterium periodonticum c 3 (6) 3 (8) +
Gemella morbillorum c 9 (38) 0
Gordonibacter pamelae d 3 (30) 0
Haemophilus influenzae 19 (43) 1 (4) +
Histophilus somni d,f 9 (18) 0 +
Leptotrichia buccalis 492 (1,104) 0 + + + +
Neisseria gonorrhoeae 127 (250) 1 (2) + +
Neisseria meningitidis 336 (821) 1 (2) + + +
Neisseria sicca c 3 (8) 4 (35)
Neisseria subflava c 4 (12) 0
Porphyromonas gingivalis 802 (2,588) 7 (72) ++ + +
Rothia mucilaginosa 24 (17) 1 (2) +
Streptobacillus moniliformis d,f 8 (23) 0
Streptococcus agalactiae 7 (27) 0 + +
Streptococcus dysgalactiae d 2 (8) 0 +
Streptococcus equi d,f 29 (101) 0 + +
Streptococcus gallolyticus d,f 8 (11) 0 +
Streptococcus gordonii 882 (3,397) 1 (8) + + + +
Streptococcus mitis 88 (161) 1 (37) ++ + +
Streptococcus mutans 21 (67) 0
Streptococcus pneumoniae 144 (339) 1 (8) + + +
Streptococcus pyogenes 14 (32) 1 (8) + +
Streptococcus sanguinis 850 (3,272) 1 (4) + +
Streptococcus suis d,f 2 (3) 0 +
Tannerella forsythia 1,099 (11,279) 10 (137) ++ + +
Treponema denticola 917 (6,106) 3 (15) ++ + + +
Veillonella parvula 96 (109) 0 +
Metagenomic data from G12 and B61 and proteomic data from G12, B17, B61 and B78. +, gene(s) detected;  
++, gene(s) and protein(s) detected.
aIncludes only pathogens with valid entries in the PATRIC database. Only taxa represented by more than one DNA contig are 
shown. All pathogens are known inhabitants of the human oral cavity, as confirmed by cross-referencing with HMP data for  
supragingival dental plaque. bPutative function based on gene homology and NCBI annotation; functionality was not  
independently validated. cReference genome sequencing and annotation incomplete. dNot a prevalent inhabitant of the oral 
cavity; not present in the Human Oral Microbiome Database (HOMD). eTentative identification; sequences correspond almost 
exclusively to mobile genetic elements. fPutative zoonosis.
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using this method (Table 1 and Supplementary Table 3), show-
ing a wide range of virulence factors associated with adhesion and 
aggregation (for example, adhesins and lectins) and parasitism (for 
example, phospholipases, hemagglutinins and hemolysins), as well as 
extensive machinery for horizontal gene transfer (for example, pilin, 
CTn and phage sequences). In several cases, we detected both the 
virulence-associated gene and its protein product, for example, Msp 
and major sheath protein in T. denticola and Rgp and Arg-gingipain in 
P. gingivalis. Arg-gingipain and Lys-gingipain, another extracellular 
cysteine proteinase identified by proteomic evidence, are highly anti-
genic and extremely abundant in P. gingivalis, accounting for 10% 
of the total protein produced by the organism27. Notably, we also 
detected type IV fimbrilin, an outer membrane protein variant associ-
ated with virulent P. gingivalis strains28.
Antibiotic	resistance
The human microbiome is an important site of horizontal gene 
transfer and a potential reservoir of antimicrobial resistance29. 
Metagenomic studies of modern dental plaque have found a wide 
range of predicted genes related to resistance to diverse antibiotics 
and toxic compounds30. The antiquity of bacterial antibiotic resist-
ance genes has recently been tested in permafrost soils dating to the 
Pleistocene31, but, until now, the antiquity of antibiotic resistance in 
human microbiota before the use of therapeutic antibiotics had not 
been investigated.
Using both automated and manual search strategies, we identi-
fied within ancient dental calculus numerous DNA sequences with 
homology to antibiotic resistance genes found in oral and pathogenic 
bacteria, including genes for multidrug efflux pumps and native resist-
ance genes to aminoglycosides, β-lactams, bacitracin, bacteriocins 
and macrolides, among others, as well as a near-complete plasmid-
encoded conjugative transposon carrying efflux pump genes with 
high homology to CTn5 of Clostridium difficile (Supplementary 
Table 4). Although the exact function of these genes in our samples 
is unclear, their presence nevertheless demonstrates that the biomo-
lecular machinery for broad-spectrum, low-level antibiotic resistance 
has long been present in the human microbiome, illustrating how the 
oral microbiome functions as both a source and a reservoir of new 
antibiotic resistance23.
Pathogen	genome	reconstruction:	T. forsythia
T. forsythia (formerly Bacteroides forsythus and Tannerella forsythensis) 
is an anaerobic, Gram-negative member of the phylum Bacteroidetes 
and is a known inhabitant of supragingival and subgingival plaque32. 
It is associated with advanced forms of periodontal disease and has 
been reported in atherosclerotic lesions7. On the basis of 16S rRNA 
gene data, T. forsythia was observed to be at moderate abundance 
(0.09–0.84%) in the dental calculus of one individual (G12) and, as a 
pathogen of interest, was selected for genome reconstruction.
Using a conservative mapping strategy, a total of 10,991 contigs 
were recruited to the ancient T. forsythia genome reconstruction, at a 
mean nucleotide depth of coverage of 5.7 (Fig. 2a). Ninety-one percent 
of T. forsythia genes (n = 2,799) were mapped by at least one contig, 
and unmapped genes included 94 transposases, transfer factors and 
other mobilization genes that may be specific to the T. forsythia ATCC 
43037 reference genome strain used for alignment. The largest gap in 
our genome reconstruction, which spanned ~48,000 bp and 53 genes, 
corresponded to a complete conjugative transposon carrying putative 
tetracycline resistance genes that was absent in our reconstructed 
ancient T. forsythia genome. In addition to genetic sequences, tandem 
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mass spectrometry (MS/MS) identified 118 
peptides belonging to 10 T. forsythia proteins 
(Fig. 2a). Of these proteins, nine were outer 
membrane or S-layer proteins, seven had a known function and 
four were antigenic: T. forsythia surface protein A (TF2661-2, tfsA), 
T. forsythia surface protein B (TF2663, tfsB), outer membrane protein 41 
(TF1331, omp41) and one hypothetical protein (TF2339)33.
Several virulence factors and antigenic proteins have been identified 
in T. forsythia (Fig. 2a), including Bacteroides surface protein A (BspA), 
dipeptidyl peptidase-4 (dppIV), tfsA and tfsB, among others27,33. The 
genes encoding each of these virulence factors were present in our 
reconstruction. The glycosylated T. forsythia S-layer proteins tfsA and 
tfsB are directly involved in hemagglutination, adhesion and tissue 
invasion34. They are also unique and are species diagnostic, as they 
have no homology to other known S-layer proteins or glycoproteins35. 
DNA and protein coverage of tfsA and tfsB was high in our data set; for 
example, 10 contigs comprising 116 reads mapped to the TF2663 (tfsB) 
gene (Fig. 2b), and we identified 65 spectra belonging to 27 unique tfsB 
peptides (Fig. 2c,d). Given that functional T. forsythia S-layer protein is 
essential for host immune evasion and biofilm coaggregation34, the dis-
covery of abundant, well-preserved S-layer gene and protein sequences 
makes ancient dental calculus an excellent candidate for investigating 
the evolution of periodontal pathogenesis in humans.
MS/MS	analysis	of	host	immunity	and	disease	pathogenesis
Despite dense microbial colonization and the regular introduction 
of foreign substances, the oral cavity is effective at preventing most 
infections. At least 45 antimicrobial gene products acting as early 
responders of the innate immune system have been identified in 
saliva and gingival crevicular fluid36. We identified 43 human proteins 
within ancient dental calculus, of which 25 are involved in the innate 
immune system (Fig. 3a). Eight of these proteins have demonstrated 
antimicrobial properties and include cationic peptides (α-defensin 
and azurocidin), metal ion chelators (calgranulin A, calgranulin B 
and lactoferrin), protease inhibitors (myeloperoxidase) and bactericidal 
proteins (bactericidal permeability-increasing protein, lysozyme C 
and peptidoglycan recognition protein 1). Expression of many of 
these proteins is specific to a particular cell type and even a particular 
subcellular component (for example, azurocidin is specific to neu-
trophil lysozomic azurophilic granules), allowing highly resolved char-
acterization of the immune system response. Approximately one-third 
of the identified human proteins were shared by ancient and modern 
calculus (Fig. 3b), and functional profiles were highly similar (Fig. 3a). 
In contrast, ancient tooth roots were distinct, both in protein com-
position and function and being dominated by collagens and other 
proteins involved in mineralized tissue (biglycan, periostin) and vas-
cular (prothrombin) development and maintenance.
The STRING resource37 was used to investigate functional inter-
action networks among the human proteins in ancient dental cal-
culus. A large number of functional interactions were predicted 
(Fig. 3c), and 79% of proteins (n = 34) were functionally connected 
to at least one other protein in the network. Immunoglobulin heavy 
chain (IgA and IgG) and light chain (kappa) peptides were detected 
in ancient calculus, as was α-amylase, a salivary enzyme that breaks 
down dietary starch; however, the majority of proteins were related to 
the innate immune system. Human proteins in ancient dental calculus 
were strongly enriched in extracellular (P value of 3.2 × 10−12, false 
discovery rate (FDR)-corrected) and secretory (P value of 4.3 × 10−9, 
FDR-corrected) proteins, mostly of neutrophilic origin. Extravasated 
neutrophils are recruited to sites of injury by IgG and have a life span 
of less than 24 h38; thus, neutrophil proteins are only released into 
calcifying dental plaques during active infection and inflammation. 
Relatively few human cellular proteins were found, suggesting that 
immune cells do not invade the calcifying plaque but rather release 
antimicrobial substances from the junctional and pocket epithelia, a 
process that is consistent with neutrophil ‘frustrated phagocytosis’ 
(ref. 39) and NETosis40. Human proteins in ancient calculus were 
significantly enriched in biological processes related to inflammation, 
innate immunity and host defense, as well as in molecular functions 
such as cell surface, protease and glycosaminoglycan binding (Fig. 3d). 
The observation of an abundance of inflammatory (myeloperoxidase, 
azurocidin, lysozyme, calprotectin and elastase) and anti-inflammatory 
(α-1-antitrypsin and α-1-antichymotrypsin) innate immune system 
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Figure 3 Metaproteomic comparison of human 
proteins in modern and ancient dental samples. 
(a) Functional characterization of human 
proteins identified in modern dental calculus 
(two individuals), ancient dental calculus  
(four individuals) and ancient tooth roots  
(four individuals). (b) Venn diagram of shared 
human proteins by sample type. (c) STRING 
network representation of human proteins 
identified in ancient dental calculus; nodes 
are labeled by protein name and colored in 
accordance with functional categories and 
connections (gray) to predicted functional 
partners. The network is set to medium 
confidence (0.4) for all active prediction 
methods. (d) Gene ontology categories  
with significant enrichment (P < 0.001,  
FDR-corrected) in ancient dental calculus  
for biological processes (black) and  
molecular functions (white) related to  
proteinase regulation, substrate binding  
and innate immune function. Enrichment  
is calculated relative to the human genome 
using the STRING-embedded AmiGO term 
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proteins in ancient dental calculus, coupled with morphological evi-
dence of attachment loss and alveolar recession, is strongly supportive 
of active periodontal inflammation and disease.
In addition to this host immunological data, we identified oral patho-
gens and bacterial virulence proteins in ancient and modern dental 
calculus known to provoke strong immunological reaction and to con-
tribute to periodontal pathogenesis (Supplementary Table 3), most 
notably P. gingivalis (gingipains), T. forsythia (S-layer proteins) and 
T. denticola (major sheath protein). P. gingivalis has recently been 
shown to stimulate neutrophils to release resistin, a protein implicated 
in acquired insulin resistance41. Resistin may exacerbate the progres-
sion of type 2 diabetes42, and, interestingly, we identified resistin on the 
basis of reasonably abundant evidence (36 spectra, 9 unique peptides) in 
ancient dental calculus. Resistin was also identified in modern calculus 
(seven spectra, five unique peptides) but not in ancient tooth roots.
Ancient	dietary	reconstruction
Given current challenges in nutritional health and obesity43, a growing 
interest in dietary aspects of the hygiene hypothesis44 and a recent study 
suggesting shifts in the ancient oral microbiome associated with periods 
of agricultural transition11, there is great interest in better understand-
ing the evolutionary history of the human diet. However, paleodietary 
reconstruction is made difficult by the generally poor preservation of 
plants and small animals in the archaeological record. Stable isotope 
analysis of human bone and dental calculus–based plant microfossil 
research have broadened our knowledge of past dietary practices, but 
these tools are insufficient to characterize many major dietary compo-
nents at high taxonomic resolution. Ancient DNA–based approaches 
offer great advantages and have been used to identify dietary compo-
nents from archaeological feces (coprolites), as well as to investigate plant 
remains directly45. However, as coprolites and preserved plant remains 
are relatively rare, we sought to characterize dietary information from 
dental calculus using both biomolecular and conventional methods.
From our metagenomic sequence reads, a total of 487 reads (0.0003%) 
were confidently identified as eukaryotic organelle sequences; of these, 
266 were assigned to the kingdom Viridiplantae, and 21 were assigned 
to the kingdom Animalia. Within these kingdoms, most of the organelle 
reads mapped ambiguously to multiple organisms or genera, leaving 
only 20 reads that could be positively identified at a subfamily level. 
Of these 20 reads, 17 were of host origin, and the remaining 3 reads 
d
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and distance was calculated using a Jukes-Cantor substitution model. Tree scale bars indicate nucleotide substitutions per site. mtDNA, mitochondrial 
DNA. (d) One sequence aligned to two accessions of bread wheat only. (e–h) The microfossils recovered from ancient human dental calculus yielded 
morphological matches to animal collagen fibers (e), a smooth long-cell phytolith (f) and starch granules of the grass tribe Triticeae (g) and the legume 
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matched diagnostic mitochondrial sequences for pig/boar (Sus spe-
cies), crucifer (Brassica species) and bread wheat (Triticum aestivum). 
Analysis of assembled contigs additionally identified one putative sheep 
(Ovis species) and several human (n = 326) nuclear genomic sequences 
(Fig. 4a–d). Although previous studies have reported trace animal 
domesticate DNA contamination (from cattle, pig and chicken) in some 
PCR reagents46, we found no evidence of such contamination, and addi-
tionally wheat, crucifers and sheep are not part of this supply chain. The 
discovery of preserved dietary biomolecules is consistent with previous 
observations of intact dietary microfossils, such as starch granules, 
in archaeological dental calculus10 and with reports of wheat and cas-
sava (tapioca) chloroplast DNA in the dental plaque of living subjects4. 
Turning to proteins, we identified one putative dietary plant protein, 
chloroplast glyceraldehyde 3-phosphate dehydrogenase (GAPDH), in 
ancient calculus, but disambiguation below the phylum Viridiplantae 
was not possible. Faunal proteins were not confidently identified within 
ancient dental calculus, but we did identify bovine β-lactoglobulin, 
a milk protein, in modern dental calculus, demonstrating that recovery 
of dietary animal proteins from dental calculus is possible.
Because our discovery of dietary biomolecules in dental calculus is 
new, we sought to validate our results using independent paleodietary 
methods. Microfossil analysis of ancient dental calculus yielded mor-
phological matches to animal connective tissue fragments (n = 2; Fig. 4e), 
an unidentified monocot phytolith (Fig. 4f), plant bast fibers (n = 3) 
and starch granules consistent with the cereal tribe Triticeae (n = 27; 
Fig. 4g) and the legume family Fabaceae (n = 1; Fig. 4h), among other 
debris (Supplementary Fig. 5). Stable isotope analysis of human bone 
collagen (Fig. 4i) from the four ancient human individuals indicated 
a mixed diet of C3 terrestrial plant and animal resources typical of 
Central European populations from the late Mesolithic through the 
medieval period47–50. Zooarchaeological analysis of food waste at the 
site confirmed the presence of pig or boar (Sus species; Fig. 4j) and 
sheep or goat (Caprinae; Fig. 4k), as well as cattle (Bos species) and 
equids (Equus species).
Biomolecular analysis of dental calculus thus yields complementary 
dietary information compared to conventional methods, as well as 
new findings. The high taxonomic precision of genetic approaches 
allows closely related taxa (for example, Caprinae) to be distinguished 
in the absence of diagnostic skeletal elements, and under-represented 
plant taxa, such as Brassica, can be identified without the biological 
and taphonomic biases that compromise macro- and microfossil pres-
ervation of leafy greens and vegetables.
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Figure 5 Evidence of microscopic and biomolecular preservation of  
ancient dental calculus. (a) Labiolingual section of a mandibular incisor  
with dental calculus (arrow) on the labial crown surface; both dentine and  
cementum within the tooth root show extensive evidence of postmortem  
alteration. Scale bar, 2 mm. (b) EDS visualization of calcium (red) and  
silicon (green) shows that silicon is restricted to the surface except for one  
biogenic silicon inclusion (arrow). Scale bar, 200 µm. (c) Detail of dental  
calculus, which exhibits a layered structure suggesting outward-downward incremental growth. Scale bar,  
100 µm. (d) Detail of a stained section showing Gram-negative (red) and Gram-positive (blue) bacteria. Scale bar,  
10 µm. (e) Detail of a Hoechst-stained section showing abundant in situ double-stranded DNA. Scale bar, 20 µm. (f) Detail of the calculus matrix 
containing numerous lacunae of filamentous microorganisms (arrow), some of which are mineralized (arrowhead). (g) In another area, the matrix contains 
both unmineralized (arrow) and mineralized (arrowhead) lacunae of microorganisms resembling cocci. Scale bars, 5 µm. (h) Proportions of human and 
bacterial proteins identified in ancient and modern samples. (i) DNA extraction yields from modern (M) and ancient dental calculus (red), dentine (blue 
and orange) and alveolar bone samples (yellow). (j) Comparison of microbial communities in ancient dental samples (squares) to those in diverse publicly 
available samples (circles). 16S rRNA data were generated by shotgun sequencing (S) and targeted amplification and sequencing of hypervariable regions 
(V3, V5, V6), followed by OTU clustering. Ancient metagenomes (n = 38) were plotted within a network where distance scales with OTU community 
similarity. Modern metagenomes with >20% shared community are shown connected by black lines, and ancient metagenomes with >20% shared 
community are connected by green lines. A total of 315 GenBank studies were recruited to the network. Ancient metagenomes segregate into two distinct 
groups: ancient dental calculus samples cluster tightly together, are connected by thick lines and show similarity to modern metagenomes of primarily 
human and oral origin, and ancient dentine and abscessed bone tissue samples form a more diffuse cluster and recruit primarily soil and environmental 
metagenomes. Carious dentine forms an intermediate cluster that shares OTUs with both human-associated and environmental sources.
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Taphonomy	and	contamination
Postmortem taphonomy and contamination pose challenges in 
ancient biomolecular research. To address these potential problems 
in our data set, we employed multiple protocols for authenticating 
our data, including scanning electron microscopy (SEM), energy-
dispersive X-ray spectroscopy (EDS), optical microscopy, Raman 
spectroscopy, protein damage analysis, genetic network analysis and 
probabilistic genetic source tracking.
After death, environmental microbes are known to infiltrate the 
dentition, causing substantial tissue degradation, loss of organic 
matter and altered mineralization patterns in dentine and cementum 
(Supplementary Fig. 6)51. We observed, however, little evidence of 
postmortem alteration in ancient dental calculus samples (Fig. 5a). 
EDS imaging showed a thin deposit of silicon-rich soil matrix only on 
the dental calculus surface (Fig. 5b), and no evidence of altered min-
eralization was observed within ancient dental calculus, a finding that 
we confirmed by Raman spectroscopic comparison with modern con-
trols (Supplementary Fig. 7). During life, growth of dental calculus is 
appositional8,52, resulting in a laminar cross-sectional structure char-
acterized by alternating bands of Gram-positive and Gram-negative 
bacteria (Supplementary Fig. 8), a pattern we also observed in ancient 
calculus (Fig. 5c,d). DNA fluorescent dye showed a similar distri-
bution of double-stranded DNA in ancient and modern calculus, in 
many cases resolving to individual cells (Fig. 5e and Supplementary 
Fig. 9) corresponding to a diverse range of in situ bacteria embedded 
within undisturbed dental calculus matrix (Fig. 5f,g).
Ancient dental calculus yielded microbial (n = 239) and human 
(n = 43) proteins in the same relative proportion and with similar 
functions as in modern controls (Figs. 3a and 5h, and Supplementary 
Fig. 10), whereas only human proteins (n = 53) were confidently iden-
tified from tooth roots and bone. Damage analysis of dental calculus 
proteins showed a higher proportion of spontaneous, non-enzymatic 
post-translational modifications in ancient samples compared to 
modern controls; however, both modern and ancient dental calculus 
peptides exhibited relatively high proportions of non-tryptic cleavage 
(>10%), an observation consistent with in vivo exposure to bacterial 
and immune system proteases (Supplementary Fig. 11).
Total DNA recovery from ancient dental calculus (5–437 ng 
DNA/mg calculus) was comparable to that for modern calculus and 
one to three orders of magnitude greater than from paired dentine 
(0.3–0.5 ng/mg), carious dentine (0.2 ng/mg) and abscessed bone 
(0.4 ng/mg) (Fig. 5i). Analysis of 16S rRNA phylotypes using a new 
network analysis tool developed for this study showed that the bac-
terial communities within ancient dental calculus closely resembled 
published human oral microbiomes and were distinct from the com-
munities observed in ancient dentine and bone, which clustered 
primarily with published soil samples, indicating environmental 
contamination after death (Fig. 5j and Supplementary Fig. 12). This 
pattern was found to be robust to extraction method, decontamina-
tion method, primer selection, sequencing method and interindi-
vidual variation. Reanalysis of our data using the methods employed 
by HMP3 yielded equivalent results (Supplementary Figs. 13–15) 
that were also confirmed using the Bayesian tool SourceTracker53 
(Supplementary Fig. 16). Ancient dental calculus is thus shown to 
be a remarkably well-preserved biological material that allows direct 
and detailed investigations of the ancient oral microbiome.
DISCUSSION
Dental calculus is among the richest biomolecular sources yet iden-
tified in the archaeological record. Given the exceptional preserva-
tion of DNA within dental calculus (5–437 ng/mg), next-generation 
shotgun sequencing libraries can be built from milligrams of mate-
rial, thereby reducing typical sample requirements for ancient DNA 
analysis by two orders of magnitude. We demonstrate that the red 
complex pathogens T. forsythia, P. gingivalis and T. denticola have long 
been associated with periodontal disease, despite changes in lifestyle, 
hygiene and diet since the medieval period. We confirm the long-term 
carriage of opportunistic pathogens in the human oral cavity, includ-
ing the causative agents of oral and respiratory diseases, as well as 
bacteria implicated in the progression of cardiovascular disease and 
the formation of arterial plaques. We find genetic evidence that the 
human oral cavity has long harbored genes with homology to puta-
tive antibiotic resistance genes, the first such demonstration, to our 
knowledge, in an ancient human–associated sample. We reconstruct 
the genome of the periodontal pathogen T. forsythia without previ-
ous enrichment and identify the absence of a complete conjugative 
transposon carrying putative tetracycline resistance genes found in 
the reference strain. We report for the first time, to our knowledge, 
the presence of well-preserved proteins within ancient dental calculus 
and show that, although the dental calculus metagenome is domi-
nated by bacterial DNA (>99%), the dental calculus metaproteome 
contains high proportions of both host and microbial proteins of clini-
cal significance. Because the growth of calculus is appositional with-
out remodeling, it may offer a potential solution to the ‘osteological 
paradox’ in studies of ancient disease54, and, given that proteins are 
known to survive longer in the archaeological record than DNA, den-
tal calculus may allow the recovery of valuable proteomic data from 
deep time periods that are out of reach using genomic technologies. 
Finally, we report the first plant and animal DNA sequences recovered 
from ancient dental calculus; these sequences allow greater taxonomic 
precision than is currently possible using microfossil or stable isotope 
paleodietary techniques. Dental calculus is a robust, long-term bio-
molecular reservoir of ancient disease and dietary information, and 
it has important implications for the fields of medicine, microbiome 
research, archaeology and human evolutionary studies.
URLs. Graphviz package, http://www.graphviz.org/; GitHub, https://
github.com/jfmrod/metagenome-sample-network-generator.
METhODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Illumina and 454 genetic data have been depos-
ited in the NCBI Short Read Archive (SRA) under the project acces-
sion SRP029257 and sample accessions SRS473742–SRS473771 and 
SRS480529–SRS480539 and to MG-RAST55 under project accession 
365 and accessions 4486524.3, 4486533.3, 4486537.3, 4486539.3, 
4486540.3, 4486544.3, 4486613.3, 4486614.3, 4486617.3, 4487224.3–
4487231.3, 4487233.3–4487235.3, 4487237.3–4487248.3, 4488534.3–
4488536.3, 4488542.3, 4517539.3, 4530391.3, 4530438.3, 4530439.3 
and 4530473.3–4530475.3. Proteomics data have been deposited in the 
ProteomeXchange Consortium via the PRIDE partner repository56 
with the data set identifier PXD000412 and accessions 34605–34628. 
Computer source code for the network analysis in Figure 5j has been 
deposited to GitHub (see URLs).
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Study design and samples. Narrative and graphical overviews of the study 
design are provided in the Supplementary Note and Supplementary Figure 17. 
Archaeological material was obtained from the medieval St. Petri church and 
convent complex in Dalheim, Germany (Supplementary Fig. 18), and radio-
carbon dated to c. 950–1200 CE (Supplementary Table 5). The assemblage 
was evaluated for pathologies (Supplementary Table 6), and dental tis-
sues from four well-preserved adult skeletons (G12, B17, B61, B78) and two 
fauna (F1, F5) were selected for further analysis (Supplementary Figs. 1, 19 
and 20). Additionally, dental tissues from nine modern controls (P1–P5, P7, 
P8, P10, P13) with known dental health histories (Supplementary Table 7) 
were obtained under informed consent, and protocols were approved by the 
Zürich Ethics Commission (KEK ZH-Nr. 2012-0119).
Microscopy and spectroscopy. A mandibular incisor from B78 was sectioned 
longitudinally and examined according to standard protocols with a Tescan 
VEGA SEM using backscattered electron (BSE) imaging and EDS with a Si(Li) 
detector. Dental calculus deposits from B78 and P3 were fixed, decalcified and 
prepared into serial thin sections using modified standard protocols, followed 
by Gram and Hoechst staining and visualization using a Zeiss Axio Imager 
M2 and a Leica DMI6000 B microscope. Microfossils were obtained from 
dental calculus (G12, B17, B61, B78) and dental calculus/crown cementum 
(F5) deposits (Supplementary Table 8) using an incremental HCl decalcifica-
tion protocol (Supplementary Note) and visualized using a Zeiss compound 
microscope under white and polarized light to identify pollen, phytoliths, 
starch granules and other debris (Supplementary Table 9) by comparison to 
reference collections. To evaluate mineralogical composition, Raman spec-
troscopy was applied to six calculus (G12, B17, B61, B78, P3, P13), nine den-
tine (G12, B17, B61, B78, P4, P5, P7, P8, P10) and five soil matrix (M1–M5) 
specimens using a HORIBA XploRA instrument (100× magnification and 
532-nm laser wavelength) and analyzed for the main PO4
3−  peak position and 
peak area, as well as the peak intensity ratios of C-H (~2,940 cm−1) I(CH) and 
main phosphate peak I(P) (Supplementary Table 10).
Isotope ratio mass spectrometry. Rib specimens from G12, B17, B61 and B78 
were cleaned by abrasion, and collagen was extracted according to the method 
of Richards and Hedges57 with an additional ultrafiltration step. Carbon and 
nitrogen isotopic values were measured in duplicate using a Thermo-Finnighan 
Delta XP continuous-flow isotope-ratio mass spectrometer following combus-
tion in an elemental analyzer FLASH EA 2112 (Supplementary Table 11).
DNA extraction. Ancient samples were extracted in a dedicated ancient DNA 
laboratory at the University of Zürich Centre for Evolutionary Medicine in 
accordance with established contamination control precautions and workflows. 
DNA was extracted from dental calculus (G12, B17, B61, B78, P2), dentine 
(G12, B17, B61, B78), carious dentine (B17), abscessed alveolar bone (B78) and 
burial matrix (M1–M5) by phenol-chloroform extraction followed by Qiagen 
MinElute column purification (Supplementary Tables 12–17). Burial matrix 
and NaOCl-decontaminated dentine were tested for the presence of endog-
enous human DNA using targeted PCR and qPCR (Supplementary Tables 18 
and 19). To optimize DNA extraction from dental calculus, five extraction 
buffers (A–E) and three decontamination methods were tested and compared. 
Two extraction buffers (A, 0.45 M EDTA, 10% proteinase K; B, 0.1 M EDTA, 
10% proteinase K, 10 mM Tris-HCl, 10 mM NaCl, 2% SDS, 5 mM CaCl2, 
40 mM DTT) and three decontamination methods (2% NaOCl, 0.5 M EDTA 
wash, none) were selected for further analysis and were used in combination 
to produce nine DNA extracts from B61 and G12 dental calculus.
DNA library construction and sequencing. DNA extracts from the optimiza-
tion experiment were built into nine shotgun libraries using a NEBNext Quick 
DNA Library Prep Master Mix Set (e6090) with DNA oligonucleotides con-
taining a sample-specific multiplex index sequence (Supplementary Fig. 21 
and Supplementary Table 20). Libraries were amplified with Phusion HS II 
enzyme and sequenced on one lane of an Illumina HiSeq 2000 using single-
end 1 × 100-bp chemistry, resulting in 93,677,545 reads after the removal of 
low-quality sequences (Illumina CASAVA 1.8.0, default settings, sequences 
<25 bp and/or with Phred scores <35 removed; Supplementary Table 21). 
Separately, 30 16S rRNA gene amplicon libraries were generated from dental 
calculus (G12, B17, B61, B78), dentine (G12, B17, B61, B78), carious den-
tine (B17) and alveolar bone abscess (B17) ancient DNA extracts generated 
using extraction buffer A and without previous decontamination. Universal 
primers targeting variable regions V3, V5 and V6 of the 16S rRNA gene were 
developed and tested in silico (Supplementary Tables 22 and 23) and in vitro 
(Supplementary Fig. 22). Each library was generated from a minimum of 
three amplifications (30–35 cycles) using Phusion HS II enzyme and 454 
amplicon Fusion primers with multiplex identifiers (MIDs), and pooled 454 
libraries were sequenced with a Roche GS Junior, resulting in 170,807 reads 
after the removal of low-quality sequences (Roche GS RunProcessor, default 
settings; Supplementary Table 24).
16S rRNA taxonomic classification. A reference data set containing full-
length 16S ribosomal RNA sequences was constructed from the NCBI GenBank 
database, whereby all publicly available 16S ribosomal gene sequences found in 
the NCBI GenBank database were downloaded, screened for chimeras using 
uchime58, aligned using the INFERNAL aligner59 v1.0.2, trimmed and clustered at 
a sequence identity cutoff of 98% with a hierarchical clustering algorithm using 
sequence identity as the measure of distance and single linkage as the cluster 
metric. This data set has high overlap with both the Greengenes60 (90%) and 
RDP61 (92%) databases and was constructed to standardize filtering and align-
ment methods, as well as to streamline GenBank data retrieval for network 
analysis. Amplicon and shotgun sample reads were aligned to the reference 
OTU data set, and reads with a bit score of <40 or negative structure score were 
discarded. Sample reads were mapped to the reference OTUs by assigning the 
OTU ID of the most similar reference sequences. Conflicting OTU IDs were 
discarded. OTUs containing 16S rRNA gene sequences belonging to a refer-
ence genome or culture collection were assigned the consensus taxonomy of 
all such sequences in the OTU. In the case of OTUs that contained no reliable 
source of taxonomy, the taxonomy of the OTU was inferred by decreasing 
the clustering threshold until the point at which the OTU was merged with 
another in which sequences with reliable taxonomy existed.
Network analysis. Network analysis of community similarity was performed 
to compare the microbial communities of ancient dental samples to each 
other and to environmental samples deposited in GenBank and MG-RAST 
(project 128). Only environmental samples with at least 20 OTUs were 
considered (1,818 of 37,689), and only samples with at least 20% similarity 
to one of the ancient samples are shown in the network (315 of 1,818). The 
similarity between a pair of samples was calculated as the number of shared 
OTUs divided by the total number of different OTUs found in both samples. 
The network was rendered using the neato program from the Graphviz 
package (see URLs).
Phylogenetic tree. Ancient dental calculus, amplicon and shotgun OTU tables 
were merged, and a full-length 16S rRNA sequence representative for each 
OTU was chosen. Phylogenetic relationships were inferred with FastTree62 
v2.1.3 (generalized time-reversible model).
Validation of results using the RDP and QIIME pipelines. To confirm 
that the taxonomic characterization of ancient dental samples was robust 
to database choice and clustering parameters, the 16S rRNA amplicon data 
were reanalyzed using the Greengenes database (v.4Feb2011) and the RDP 
Pyrosequencing61 and QIIME63 pipelines. Only reads of ≥70 bp with 100% 
identity to both forward and reverse primers were analyzed. OTUs were clus-
tered at 97% identity, and singleton OTUs were discarded (Supplementary 
Table 25). The OTU table was rarefied to 1,265 sequences/sample and ana-
lyzed at the L2, L5 and L6 levels. Alpha and beta diversity were calculated 
using QIIME default parameters. The BIOM file for these data is available as 
Supplementary Data Set 1. This OTU table was merged with an OTU table 
generated from the HMP data set using the same parameters, and the two data 
sets were compared using Principal Coordinates Analysis; the BIOM file for 
these data is available as Supplementary Data Set 2.
Source tracking. To test for contamination in the ancient dental samples, 
Bayesian microbial source tracking53 was performed (1,000 ‘burn-in’ iterations 
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using Gibbs sampling with 25 random restarts) on the merged OTU file using 
HMP plaque, HMP skin, HMP gut and ancient tooth root (environmental 
proxy) as sources.
Dietary DNA analysis. Shotgun reads ≥75 bp in length were searched against 
a complete collection of full mitochondrial and chloroplast genome sequences 
published as of July 2012 (>6,000 organelle genomes) using BLASTN. Results 
were accepted only if they exhibited 100% query coverage and 100% sequence 
identity, were not hits to 16S or 23S rRNA genes and did not match more 
than one genus perfectly, and any secondary hits outside the genus of the 
first hit had to show at least two diagnostic point mutations relative to the 
perfect hit.
Total taxonomic characterization of dental calculus. Library reads were 
pooled by individual (B61, S1–S4; G12, S5–S8) and de novo assembled into 
2,005,273 contigs using Velvet64 v.1.02.3 (k-mer length of 29 bp, minimum 
of 100-bp contig length) (Supplementary Table 26). Contigs were searched 
against the NCBI nr and gss databases available as of July 2012 using Megablast, 
filtered for highly unique, high-scoring top hits (>95-bp alignment, >97% 
identity, E value of <1 × 10−14). A total of 61,584 contigs passing these filters 
were assigned taxonomy.
Pathogen analysis. Contigs were further filtered to remove contigs with sec-
ond hits of comparable quality and >90% identity to other taxa, resulting in 
53,924 highly unique contigs that can be reasonably assigned to a single spe-
cies. Species-level assignments were then cross-referenced against the PATRIC 
database19, resulting in 40 putative pathogen identifications. To determine 
whether these species assignments were reasonable for the oral cavity, we 
applied the same BLAST and conditional filter approach to shotgun metage-
nomic contigs reported for 109 HMP supragingival dental plaque samples 
and compared the results. Feature information for each ancient contig was 
retrieved from the top-hit BLAST results and manually screened for putative 
genes associated with virulence, drug resistance, plasmids, transposons and 
phages with annotations in PubMed records.
Antibiotic resistance analysis. Sequences for all identified taxa were screened 
for putative antibiotic resistance elements using three methods: (i) BLASTX 
search against the Antibiotic Resistance Database (ARDB)65, (ii) BLASTX 
search against the NCBI nr database followed by keyword search of trans-
lated gene function and (iii) manual search of gene annotations assigned 
to pathogens.
Genome reconstruction. All G12 contigs of ≥100 bp were searched against 
the NCBI nt and gss databases using Megablast and filtered for contigs align-
ing to T. forsythia strain ATCC 43037 with an E value of ≤1 × 10−6 within 
the top 100 hits. Filtered contigs were pooled and submitted to the BLAST 
Ring Image Generator (BRIG)66 tool for mapping. Using BRIG, contigs were 
aligned to T. forsythia strain ATCC 43037 using the Megablast search option 
and a sequence identity cutoff of ≥95%. In cases where a contig aligned to 
the T. forsythia genome more than once, the alignment with the highest bit 
score was mapped. In cases where multiple alignments with identical top bit 
scores were observed, the contig was mapped to all top bit score loci, but the 
depth of coverage for each locus was divided by the number of loci. Genes not 
mapped in the assembly and large gaps (Supplementary Fig. 23) were analyzed 
for function.
Protein analysis. Total proteins were extracted from dental calculus (G12, 
B17, B61, B78, P1, P2), dentine (G12, B17, B61, B78), carious dentine (B17), 
abscessed alveolar bone (B78) and dental calculus/crown cementum (F1, F5) 
and from four negative extraction controls using a modified filter-aided sample 
preparation (FASP)67 protocol. A total of 290,466 MS/MS spectra were gener-
ated using 3 instruments (LTQ-Orbitrap Velos, Q-Exactive Hybrid Quadrupole 
Oritrap and MaXis UHR-Qq-TOF) (Supplementary Table 27). Tandem mass 
spectra were converted to Mascot generic format using ProteoWizard v.2.2.3101 
with vendor peak picking option for MS level 2 and deisotoped and deconvo-
luted using the H-Score script68. ProteinPilot v.4 was used to analyze protein 
modification and damage patterns (Supplementary Table 28). MS/MS peak 
lists were searched using Mascot v.2.3.02 against all proteins in UniProtKB/
SwissProt as of 31 October 2012 and two custom protein databases built from 
the Human Oral Microbiome Database (HOMD)69 as of 11 October 2012 and 
all complete soil bacterial genomes in GenBank as of 22 February 2012. The 
results were further validated using Scaffold v.4.0.5, resulting in 12,609 unique 
peptide identifications resolving to 589 proteins identified with >99% confi-
dence and ≥2 unique peptides. Contaminants were identified and removed 
(Supplementary Table 29). Metadata for human proteins was retrieved using 
the GeneCards v.3 GeneALaCart tool70 and used to manually classify each 
protein into six categories: innate immune system, adaptive immune system, 
blood coagulation, digestion, structure and support, and other. Protein inter-
action and gene ontology (GO) information was obtained using STRING 9.0 
(ref. 37) in protein mode. Bacterial proteins were binned by length (group 1, 
<15 residues; group 2, >15 residues) and searched against the NCBI database 
using BLASTP (group 1, expect value 20,000, PAM30 Score Matrix; group 2, 
expect value 1,000, BLOSUM62 Score Matrix). Resulting BLASTP files were 
then parsed using MEGAN71 and analyzed for protein function using SEED 
hierarchy72.
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Chapter 6
Other contributions
Microbiota-Derived Hydrogen Fuels Salmonella Typhimurium Invasion of
the Gut Ecosystem
This study was led by Dr. Maier to investigate the process of gut ecosystem
colonization by S. Typhimurium during an infection episode. Knockout studies
in the S. Tm SL1344 showed that a non-functional copy of the Fe-Ni uptake-type
hydrogenase operon (which facilitates the consumption of hydrogen) conferred
fitness disadvantage to the mutant mice as compared to wild type S. Tm in the
gut with an unperturbed microbiota. However, the fitness disadvantage disap-
peared in a low complexity microbiota mice (or mice that did not harbor a healthy
microbiota, germ free mice, streptomycin-pre treated mice).Furthermore, S. Tm
growth also suffered when other hydrogen consuming bacteria were introduced
in the gut. Since hydrogen is not produced or consumed by the host (mice,
human), hydrogen derived from the gut microbiota seems to boost the growth
of S. Tm. As a part of this project, I was responsible for identifying genes re-
sponsible for hydrogen producing and consuming enzymes present in the gut
metagenome of six different species. This was with the aim to assess the avail-
ability of hydrogen and its metabolism in different guts.
IFN-γ hinders recovery from mucosal inflammation during antibiotic ther-
apy of Salmonella gut infection
This study was led by Dr. Dolowschiak to characterize an episode of S .Tm
infection and recovery in mice. The mice were initially orally infected and then
subsequently treated with a standard antibiotic to promote recovery. There-
after several inflammatory markers were measured at routine intervals using RT
qPCR. The measurements were made on 52 genes including a variety of cy-
tokines, chemo-attractants, granulocyte infiltration, antimicrobials, interleukins
and housekeeping genes. For each day, measurements were taken from three
mice. I was responsible for the data analysis focusing on the shift of the expres-
sion patterns over the course of infection to confirm whether these inflammatory
markers returned to their baseline values after the infection.
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Chapter 7
Concluding Remarks
A major contribution of this work has been high resolution characterization of mi-
crobial communities associated to two different anatomical sites. By using the
methods presented in this work, it is possible to supplement or partially replace
traditional culture methods in favor of whole genome shotgun sequencing ap-
proaches which have the power to identify nearly all species present in a clinical
sample with high taxonomic resolution. These methods rely solely on sequenc-
ing with minimal experimental manipulation, streamlining the detection process.
We determine that strain typing followed by near complete whole genome re-
construction is feasible using whole metagenome shotgun sequencing data for
dominant, over-represented microbes using total DNA extracted from CF spu-
tum samples.
This technique essentially builds upon the knowledge of existing comprehen-
sive multilocus sequence typing (MLST) databases of known CF pathogens to
speed up strain identification. The main advantage of this method is that pres-
ence of multiple strains can be detected for a number of different pathogens with
relative ease from routinely collected CF sputum samples without adding elab-
orate experimental work. Thus temporal changes can be tracked in strain diver-
sity to prepare comprehensive histories of infection episodes. This knowledge
can provide a detailed view of the changes that take place a microbial com-
munity during the course of infection, promoting deeper understanding of the
infection dynamics. However, the reliance of this approach upon well populated
MLST databases places constraints on the species which can be identified.
Specifically, it is only possible to carry out strain identification for species that
have been previously subjected to MLST. Thus strain typing using this genomic
technique is contingent upon availability of well populated MLST databases.
Nonetheless, as more and more species undergo experimental strain typing
we anticipate an increasing relevance of strictly genomic analysis-based tech-
niques in a clinical setting in the near future.
The MLST data can be further complemented by assembling whole
genomes to learn about possible genome rearrangements and gain of any ge-
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netic elements in the newly assembled strain. This information can be further
correlated with the strain identity to functionally characterize the strains. Using
this approach, a previously documented MLST strain of a known opportunis-
tic pathogen was detected in the sputum sample of one CF patient and it was
further characterized by assembling its near complete genome. This led to the
detection of a virulence associated secretion system (T6SS) which had pre-
viously not been widely observed in this bacterial species. Knowledge of such
virulence linked adaptations have the potential to impact the course of treatment
and is thus clinically relevant information. Gathering data about the presence of
different strain types and their virulence potential over time can help in design of
more informed treatments. Additionally, one can distinguish between infections
caused by a singular strain from those caused by a cloud of strains and also
monitor whether any of the strains can outcompete others to establish clonal in-
fections. This information is particularly relevant in case of CF patients since CF
pathogens such as p. aeruginosa are known to undergo mutations that enables
their environmental, virulent strains (responsible for causing the infection) to
adapt and thrive in the lung environment. Thus whole or partial genome recon-
struction provides a unique opportunity to build catalogues of such mutations
observed across gene sets of known function and identify evolutionary hotspots
in the pathogen genome without routinely engaging in experimental techniques.
This information is crucial to developing a thorough understanding of pathogen
evolution over the course of infection.
The sequence based analysis techniques discussed in this work represents
a powerful addition to a clinicians toolbox particularly for characterizing micro-
bial infection. Emerging adaptations such as antibiotic resistance can be de-
tected by scanning the entire community′s metagenome against the existing
antibiotic resistance databases. Since clinical testing for antibiotic resistance
is limited to bacteria that can be cultivated in laboratories, it does not account
for resistances harbored by the uncultivable fraction of the microbial commu-
nity. Thus sequence based prediction of resistances is likely to present a more
comprehensive account as compared to current culture based methods. More-
over, since sequence-based prediction of antibiotic resistance relies on direct
observation of the resistance conferring gene sets or relevant mutation, it may
be possible to detect such adaptations before they translate into an observable
phenotype that can be detected in clinical resistance testing (i.e. before the re-
sistance gene or mutation fixates in a microbial population). Such rapidity may
prove useful for aggressive infections for which time is of the essence. However,
sequence-based prediction of antibiotic resistance requires high quality, publi-
cally available datasets that have been experimentally confirmed. The develop-
ment of such databases is currently restricted by limited understanding of the
resistance conferring mechanisms. As these databases become more compre-
hensive, genomic prediction of antibiotic resistance will find greater application
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in assisting treatment design.
Next, to investigate the evolution of human associated microbial communi-
ties, we examined a calcified form of an oral biofilm (dental plaque) known as
dental calculus. We used a combination of non-targeted and 16S WGS se-
quencing to assess whether dental calculus contains meaningful information
about the ancient oral microbiome. One of the most important findings of this
study was that ancient dental calculus is a rich source of information about the
ancient oral microbial community and contians little contamination from the envi-
ronmental microbes. This finding is likely going to impact the way archaeologists
currently investigate ancient human lifestyle. It is one of the first studies to estab-
lish that dental calculus contains diagnostically useful DNA to identify members
of the ancient oral microbiota, opportunistic upper respiratory pathogens and
dietary information. This study raises important questions about the evolution
of microbes and the nature of relationship with their human host. Using calcified
plaque samples from different time periods, it is potentially possible to investi-
gate whether oral microbial community has undergone major rearrangements
in terms of its composition. Another interesting question to investigate would be
the evolution of oral pathogens. In this study, we reconstruct a near complete
genome of a periodontal pathogen and compare it to its contemporary counter-
part and identify lack of pathogenicity associated genomic islands. Since dental
calculus preserves well over extended periods of time, it can serve as an excel-
lent source to investigate ancient human health and its associated microbiota
from different eras. Cross comparison with contemporary knowledge can also
bear important implications on improving management of human health.
So far we have discussed the advantages of WGS sequencing for character-
izing human associated microbial populations. Indeed, WGS provides a promis-
ing alternative to the current culture based techniques, however it also presents
a number of shortcomings. Firstly, the untargeted nature of WGS can lead to
a potential bias for microbes with differing genome sizes such as bacteria and
fungi. Furthermore, due to their extremely large size, eukaryotic genomes re-
quire greater sequencing depth before they can be assembled compared to
bacterial genomes. Thus eukaryotic microbes are more likely to be underrep-
resented in assembled data. This shortcoming can be addressed by either in-
creasing the sequencing depth or by using enrichment protocols to capture the
eukaryotic population in combination with WGS sequencing. Another short-
coming is that current WGS data analysis tools strongly depend on availability
of well curated genomic databases. This leads to annotation of only a frac-
tion of the sequenced data at varying levels of resolution. To improve the rate
of annotation, further work is needed to build comprehensive, high-resolution
databases or development of more sophisticated binning techniques that are
able to differentiate between genomes based on their intrinsic properties. In
chapter 4, we use a combination of GC content, contig entropy and length to
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facilitate the detection of highly abundant clonal species without using homol-
ogy based searches. This was carried out with the aim of detecting previously
unknown, abundant microbes. While there were no new species detected in the
CF patients, this approach has the potential to discriminate dominant, clonal
colonizers, even previously unobserved ones and is widely applicable to sam-
ples obtained not only from clinics, but also for other microbe-rich environments
as well.
The work discussed in this dissertation has been centered around snapshot
data that provides clinically relevant information and raises interesting ques-
tions about the changes that follow in human associated microbial communities
during the course of an infection. Future work would be to apply the genomic
methods described here to build temporal histories and characterize the com-
munity dynamics in patient and healthy lungs. By determining that total DNA
from non-invasive samples such as sputum is a rich source of information about
the endogenous lung microbial community, we hope to facilitate high resolution
routine monitoring of the lung microbial community.
Detection of a possibly new, yet unnamed Achromobacter species in one CF
patient highlights the need to combine experimental and genomic techniques to
identify diagnostically useful species markers to allow accurate identification of
the infecting pathogen. To date, there has been no clear consensus on the
effect of Achromobacter infection on prognosis of CF. Accurate identification of
the infecting Achromobacter species is likely going to help clear the ambiguity
on the impact of infecting species on lung function and disease prognosis.
In this study, while most CF patients showed visibly reduced microbial diver-
sity (as expected in a diseased lung), one advanced CF patient harbored a rich
and diverse lung microbial community along with a known CF pathogen. Tem-
poral studies are required to understand the effect of a dominant colonizer on
the community structure and composition. It would be especially interesting to
investigate nature of interaction between various pathogens and other members
of lung microbial community. This can help understand the distinct changes that
occur in the lung microbiota in the presence of different pathogens.
We hope that one of the long term desirable outcomes of such studies
would be the development of microbiome based therapies to restore the healthy
commensal population and help in management (if not treatment) of complex,
polymicrobial infections.
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Appendix
Figure 7.1: Plot showing the sequencing throughput for each sample. Subject
ID on x-axis and total number of read pairs on y-axis. CF-99 was sampled twice.
Table 7.1: Table showing clinically detected bacteria and their subsequent iden-
tification using genomic analysis
107
Figure 7.2: Plot showing the percentage of non-human DNA per ml vs. total
DNA concentration. CF samples are marked in red, COPD in blue, healthy in
green and smokers in light blue.
108
Figure 7.3: Plot showing the Shannon entropy of each sample from the four
subject groups.
109
Figure 7.4: Genus level taxonomic composition of each sample. All genera con-
stituting less than 4.5% of the annotated fraction have been labeled as others.
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Table 7.3: clinically tested antibiotics for detecting resistance and results from
genomics analysis for CF-76
Table 7.4: clinically tested antibiotics for detecting resistance and results from
genomics analysis for CF-00
Table 7.5: clinically tested antibiotics for detecting resistance and results from
genomics analysis for CF-82
112
Table 7.6: clinically tested antibiotics for detecting resistance and results from
genomics analysis for CF-94
Table 7.7: clinically tested antibiotics for detecting resistance and results from
genomics analysis for CF-99
113
Table 7.8: clinically tested antibiotics for detecting resistance and results from
genomics analysis for CF-992
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Figure 7.5: Entropy Landscape plot showing lung microbial composition for CF-
99 and CD-34
115
Figure 7.6: Entropy Landscape plot showing lung microbial composition for CD-
42, CD-54, H-84
116
Figure 7.7: Entropy Landscape plot showing lung microbial composition for H-
380, H-94, S-81
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Figure 7.8: Entropy Landscape plot showing lung microbial composition for S-82
118
Figure 7.9: Phylogenetic tree showing placement of reference S. maltophilia
database strains in addition to the strain isolated from our subject CF-00 and all
strains documented in the PUBMLST database.
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